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A  adenosine (IUPAC), also common abbr. for adenine 
ampR  resistant to ampicillin 
bp  base pair 
BSA  bovine serum albumin 
C  cytidine (IUPAC), also common abbr. for cytosine 
cDNA  complementary DNA 
CDR  complementary determining region 
ctzR  resistant to ceftazidime 
dATP  deoxyadenosine triphosphate 
dCTP  deoxycytidine triphosphate 
dGTP  deoxyguanosine triphosphate 
dGTPαS deoxyguanosine 1-thiotriphosphate 
DIG  digoxigenin 
dITP  deoxyinosine triphosphate 
DNA  deoxyribonucleic acid 
dNTP  deoxyribonucleotide 
dPTP  5'-triphosphate of 6-(2-deoxy-b-D-ribofuranosyl)-3,4-dihydro-8H-
  pyrimido-[4,5-C][1,2]oxazin-7-one 
dsDNA double-stranded DNA 
DTPA  diethylenetriamene penta-acetate 
dTTP  deoxythymidine triphosphate 
dUMP  deoxyuridine monophosphate 
dUTP  deoxyuridine triphosphate 
ELISA enzyme-linked immunosorbent assay 





epPCR error-prone PCR 
epRCA error-prone RCA 
F  5-fluorodeoxycytidine 
Fab  antigen binding fragment 
FACS  fluorescence-activated cell sorting  
G  guanosine (IUPAC), also common abbr. for guanine 
GC  gas chromatography 
IgG  immunoglobulin G 
IVC  in vitro compartmentalization 
IPTG  isopropyl-β-D-thiogalactopyranoside 
IUPAC International union of pure and applied chemistry 
MS  mass spectrometry 
MMS  methyl methanesulfonate 
MNNG N-methyl-N'-nitro-N-nitrosoguanidine 
mRNA messenger RNA 
mut/ntR  mutations per nucleotide per reaction 
p3  phage coat protein three; minor coat protein of filamentous phage 
  also known as g3p, pIII 
p3∆  C-terminal domain of p3; also known as p3CT 
p6  phage coat protein six, also known as pVI 
p7  phage coat protein seven, also known as pVII 
p8  phage coat protein eight; major coat protein of filamentous phage 
  also known as pVIII 
p9  phage coat protein nine, also known as g9p, pIX 
PCR  polymerase chain reaction 





RCA  rolling circle amplification 
RNA  ribonucleic acid 
ScFv   single-chain fragment of antibody variable domains 
SD  standard deviation 
SEC  post-translational secretion pathway 
SGS  second generation sequencing, also known as NGS 
SOE-PCR splicing by overlap extension PCR 
sRCA  selective rolling circle amplification 
ssDNA single-stranded DNA 
ssRNA single-stranded RNA 
STR  streptavidin 
T  thymidine (IUPAC), also common abbr. for thymine 
TAT  twin-arginine translocation 
Ti/Tv   transitions-to-transversions-ratio 
TRIM  trinucleotide mutagenesis 
U  uridine (IUPAC), also common abbr. for uracil 
UDG  uracil-DNA-glycosylase 
UV  ultraviolet radiation 
VH  variable heavy domain of antibody 
VL   variable light domain of antibody 
Vλ  variable lambda domain of the light chain of antibody 







Protein engineering aims to improve the properties of enzymes and affinity 
reagents by genetic changes. Typical engineered properties are affinity, 
specificity, stability, expression, and solubility. Because proteins are complex 
biomolecules, the effects of specific genetic changes are seldom predictable. 
Consequently, a popular strategy in protein engineering is to create a library of 
genetic variants of the target molecule, and render the population in a selection 
process to sort the variants by the desired property. This technique, called 
directed evolution, is a central tool for trimming protein-based products used in a 
wide range of applications from laundry detergents to anti-cancer drugs. New 
methods are continuously needed to generate larger gene repertoires and 
compatible selection platforms to shorten the development timeline for new 
biochemicals. 
In the first study of this thesis, primer extension mutagenesis was revisited to 
establish higher quality gene variant libraries in Escherichia coli cells. In the 
second study, recombination was explored as a method to expand the number of 
screenable enzyme variants. A selection platform was developed to improve 
antigen binding fragment (Fab) display on filamentous phages in the third article 
and, in the fourth study, novel design concepts were tested by two differentially 
randomized recombinant antibody libraries. Finally, in the last study, the 
performance of the same antibody repertoire was compared in phage display 
selections as a genetic fusion to different phage capsid proteins and in different 
antibody formats, Fab vs. single chain variable fragment (ScFv), in order to find 
out the most suitable display platform for the library at hand. 
As a result of the studies, a novel gene library construction method, termed 
selective rolling circle amplification (sRCA), was developed. The method 
increases mutagenesis frequency close to 100% in the final library and the 
number of transformants over 100-fold compared to traditional primer extension 
mutagenesis. In the second study, Cre/loxP recombination was found to be an 
appropriate tool to resolve the DNA concatemer resulting from error-prone RCA 
(epRCA) mutagenesis into monomeric circular DNA units for higher efficiency 
transformation into E. coli. Library selections against antigens of various size in 
the fourth study demonstrated that diversity placed closer to the antigen binding 
site of antibodies supports generation of antibodies against haptens and peptides, 
whereas diversity at more peripheral locations is better suited for targeting 
proteins. The conclusion from a comparison of the display formats was that 
truncated capsid protein three (p3∆) of filamentous phage was superior to the 
full-length p3 and protein nine (p9) in obtaining a high number of uniquely 
specific clones. Especially for digoxigenin, a difficult hapten target, the antibody 
repertoire as ScFv-p3∆ provided the clones with the highest affinity for binding. 
This thesis on the construction, design, and selection of gene variant libraries 
contributes to the practical know-how in directed evolution and contains useful 






Proteiinien muokkauksella tähdätään entsyymien ja sitojareagenssien ominaisuuksien 
parantamiseen geneettisten muutosten avulla. Tyypillisiä parannettavia ominaisuuksia 
ovat sitomisvoimakkuus, spesifisyys, kestävyys, tuotto-ominaisuudet ja liukoisuus. 
Koska proteiinit ovat monimutkaisia biomolekyylejä, geneettisten muutosten 
vaikutukset ovat vain harvoin tarkkaan ennustettavissa. Siksi suosittu proteiinien 
muokkausstrategia on luoda kohdemolekyylistä lukuisia geenivariantteja ja asettaa luotu 
joukko valintakokeeseen, jonka perusteella variantit erottuvat toisistaan tavoitellun 
ominaisuuden perusteella. Tämä suunnattuna evoluutiona tunnettu tekniikka on 
keskeinen työkalu kehitettäessä proteiinituotteita, joita käytetään monenlaisissa 
sovelluksissa vaatteiden pesuaineista syöpälääkkeisiin. Proteiinituotteiden kehitystyön 
nopeuttaminen edellyttää jatkuvasti uusia menetelmiä, joilla voidaan rakentaa aiempaa 
laajempia geenikirjastoja ja niille yhteensopivia valintatyökaluja. 
Tässä työssä tutkittiin alukepidennysmutageneesitekniikan mahdollisuuksia 
korkealaatuisempien geenivarianttikirjastojen rakentamiseksi Escherichia coli-bakteerin 
soluihin. Toisessa osajulkaisussa tutkittiin rekombinaatiota menetelmänä, jolla voitaisiin 
lisätä seulottavissa olevien entsyymivarianttien lukumäärää. Kolmannessa 
osajulkaisussa kehitettiin valintaprosessi, jonka tarkoituksena oli parantaa vasta-
ainefragmenttien ilmentymistä filamenttifaagin pinnalla näyttötekniikkaa varten. 
Neljännessä osajulkaisussa testattiin geenikirjaston suunnittelustrategioita käytännössä 
kahdella eri periaatteiden mukaan monimuotoistetulla vasta-ainekirjastolla. Viimeisessä 
osajulkaisussa vertailtiin faagin eri pintaproteiineihin fuusioidun vasta-ainekirjaston 
toimintaa valintakokeiden avulla. Samalla tutkittiin vasta-ainefragmenttien Fab (engl. 
antigen binding fragment) ja ScFv (engl. single-chain fragment of antibody variable 
domains) vaikutusta valintakokeen onnistumiseen, jotta selviäisi, mikä on 
käyttökelpoisin näyttötekniikka käytössä olevan kirjaston hyödyntämiseksi. 
Tutkimuksen tuloksena kehitettiin uusi geenivarianttikirjaston rakennusmenetelmä 
nimeltään sRCA (engl. selective rolling circle amplification), joka lisää merkittävästi 
mutageneesitehokkuutta ja jopa yli satakertaistaa kirjaston muodostavien 
transformanttien määrän verrattuna tavanomaiseen alukepidennysmutageneesiin. 
Toisessa osajulkaisussa havaittiin Cre-loxP-rekombinaation olevan sovelias työkalu 
RCA-satunnaismutageneesin tuloksena syntyvän DNA-vyyhdin pilkkomiseen 
kehämäisiksi plasmidiyksiköiksi. Uusi menetelmä lisäsikin DNA:n 
transformaatiotehokkuutta E. coli-bakteeriin. Kirjastoseulontojen avulla osoitettiin, että 
kirjastosta, jossa aminohappojen vaihtelua esiintyi lähempänä vasta-aineen 
sitomiskohdan keskustaa, löytyi enemmän pienmolekyylejä ja peptidejä tunnistavia 
vasta-aineita. Ulompana keskustasta sijaitsevien aminohappojen vaihtelu puolestaan 
tuki proteiineja tunnistavien vasta-aineiden kehitystyötä. Vasta-ainekirjaston 
faaginäyttötekniikkavertailun johtopäätökset olivat, että käyttämällä filamenttifaagin 
vasta-aineiden fuusiokumppanina lyhennettyä proteiini kolmea (p3∆) pystyttiin 
eristämään runsaammin erilaisia kohdetta tunnistavia vasta-ainemolekyylejä kuin 
käyttämällä kokopitkää proteiini kolmea tai proteiini yhdeksää (p9). Erityisesti ScFv-
p3∆-formaatissa oleva kirjasto tarjosi sitomisvoimakkuudeltaan parhaita vasta-aineita 
molekyylikooltaan pienen digoksigeniinin tunnistukseen. 
Tutkimus geenivarianttikirjastojen suunnittelusta, rakentamisesta ja seulontaan 
soveltuvista valintatyökaluista lisää käytännön tietoa suunnattujen evoluutiokokeiden 






Cultivation of crop species has been practiced by humans for over 10 000 years 
and the history of selective breeding is equally long [1]. Domestication has 
gradually resulted in the variety of plant and animal species that we use at 
present to acquire food and clothes. Selective breeding is directed evolution, in 
which the desired genetical traits are favoured and the undesired disfavoured by 
allowing the progeny of the individuals carrying the desired phenotype to 
reproduce. Some traits were intentionally evolved, such as the size of a grain, 
whereas some other traits, e.g., the loss of seed shattering, seem to have evolved 
without intentional human steering [1; 2]. Similar selective practices have been 
applied to evolve micro-organisms for food processing and medicine 
manufacturing, of which for example antibiotics, are well-known and of major 
importance to the welfare of humans and their domesticated companions. 
In the early days, microbial production strains were improved without any 
knowledge of the underlying genetic features. This is a slow process due to the 
low frequency of new beneficial mutations introduced by nature. Towards 
modern times, the pace of evolution has been increased by creating genetical 
diversity with chemicals and irradiation followed by the selection for improved 
variants. However, the two most important innovations contributing to directed 
evolution were the establishment of modern recombinant DNA technology and 
the in-depth knowledge of genes and proteins. Nowadays, instead of whole 
organisms, individual genes responsible for certain traits are manipulated 
providing a knowledge-based approach for strain improvement. 
From the mid-1980s, proteins of mammalian origin have been expressed with 
high yields in micro-organisms or production cell lines by recombinant DNA 
technology [3]. Therapeutics produced by heterologous protein expression have 
provided a cost-effective or, in some cases, even the only cure for treatment of 
various human diseases and the share of recombinantly produced protein 
medicines is predicted to expand further in the future [3]. In addition to pure 
rational design of gene sequences, collections of synthetic gene variants are 
routinely generated in laboratories, and the characteristics of the variants are 
systematically explored. The collections of gene variants, also termed gene 
libraries, have become a central tool in protein engineering. 
Gene libraries are mined either by expressing each variant individually in host 
cells and analyzing the phenotypic features with an appropriate assay or by 
applying a display method (Figure 1). In display methods, every expressed 
protein variant is physically linked to the corresponding gene and the expansion 
of the desired individuals is promoted by exerting an appropriate selection 
pressure on the pool of displayed geno-phenotype units. When the share of the 
desired geno-phenotype units is enriched to a satisfying degree in the population, 
the properties of the individuals are analysed in detail. With display methods, the 
repertoires of billions of members can be explored, whereas conventional 





methods for gene library construction and use are reviewed. The results of the 
present work are novel tools for gene library construction and contain detailed 
descriptions of the potential and limitations of display methods in search for 
desired gene products. Especially issues related to the phage display of antibody 
fragments are discussed. 
 
Figure 1. Typical workflows in directed evolution experiments. Gene variants 
are created with mutagenesis methods and the desired variants in the 
population are enriched by a selection process, such as phage panning. 
Alternatively, library clones are directly separated into individual cultures, 
expressed, and screened for the desired property. 
 




2 REVIEW OF THE LITERATURE 
2.1 Methods for gene variant library construction 
2.1.1 Random mutagenesis 
2.1.1.1 Time 
DNA sequences continuously change through spontaneous mutations over time. 
Single base mutations arise naturally by chemical conversion and replication 
defects, whereas insertions and deletions are most often related to transposable 
elements [4]. In one long-term study a laboratory strain of E. coli REL606 was 
cultured in minimal growth medium over 6000 days spanning 40 000 generations 
[5]. During that time the strain had gained 627 single-nucleotide mutations and 
26 deletions, insertions or inversions. 
With this mutation rate a single mutation will appear somewhere in the genome 
in 9 days of continuous culturing. Assuming uniform distribution of mutations 
and taking into account the genome size of the strain, 4.57 × 106 bp [5], over 115 
years is needed to obtain a single mutation per 1000 bp. Because the gene density 
of E. coli is 0.911 ± 0.04 genes per 1000 bp [6], even longer time is required to 
have a mutation in every gene. It is obvious that the spontaneous mutation rate in 
E. coli is too slow for the needs of protein engineering. Notably, the rate is 
species dependent as over 100-fold higher mutation rates per genome per 
replication have been observed in lytic ssRNA viruses than in E. coli, which is 
mainly due to a lack of proof-reading activity of the RNA polymerase employed 
by the virus [7]. 
2.1.1.2 Mutator strains 
In a closer analysis of the point-mutation rates in the above-mentioned follow-up 
study on E. coli strain REL606 it was noticed that the point-mutation rate 
increased 70-fold from a natural rate of 1.6 x 10-10 (estimated upper bound) to 1.1 
x 10-8 mutations per bp per generation. This change was connected to the 
emergence of a mutator phenotype around the generation 26 500, which became 
dominant in the population before the strain achieved 29 000 generations [5]. The 
increased mutation rate was due to a defect in the mutT gene, which is coding for 
a nucleoside triphosphate pyrophosphohydrolase [8]. This enzyme selectively 
hydrolyzes 8-oxo-dGTP preventing the misincorporation of 8-oxo-dGTP into 
dsDNA [9]. 8-oxo-dGTP pairs readily with adenine causing T-A to G-C 




transversions and without mutT function the transversion rate is increased 100 – 
10 000-fold depending on the assay set-up [10; 11]. 8-oxo-dGTP is a by-product 
of normal aerobic metabolism [12] and, therefore, all organisms have evolved a 
multitude of damage prevention and repair mechanisms to protect themselves 
from the damaging influence of this and several other natural products on the 
integrity of DNA [4]. 
Knock-outs of the error-reducing mechanisms have been used to speed up the 
rate of spontaneous mutations. For example, the E. coli strain XL1-Red provided 
commercially by Agilent Technologies has disabling mutations in the above-
mentioned gene mutT, but also in mutS involved in error-prone mismatch repair 
[13] and in mutD making the DNA polymerase III deficient in 3´-5´ exonuclease 
activity [14]. The mutation rate of this strain was measured to be 5000-fold 
higher than that of the wild type, corresponding to 1 x 10-5 mutations per base 
pair per generation, i.e. 46 mutations per genome per generation [15; 16]. In a 
gene mutagenesis experiment, where a target gene of 1000 bp would be inserted 
into a pUC-series of high copy plasmids with 500 - 700 copies per cell [17], a 
mutation in five gene copies would be expected in every generation, when 
propagated in XL1-Red. 
In another example, a phage display-compatible mutD knock-out strain was 
developed and used to affinity maturate a ScFv in a high copy phagemid pHEN1 
[18]. The mutation rate in this single knock-out was estimated to be 1.7 x 10-5 
mutations per bp per generation which is on the same scale with the mutation rate 
of XL-1 Red triple mutant. With multiple rounds of growth in the mutD strain 
and subsequent affinity selections, an anti-hapten ScFv with a 100-fold increase 
in affinity for the antigen 2-phenyl-5-oxazolone was obtained. Mutator plasmids 
are another way to induce random mutations. For example, the expression of a 
nonfunctional mutD allele from a plasmid in the host to be mutated resulted in 
the replacement of the host-expressed wild-type MutD protein in the DNA 
polymerase III complex and, consequently, to a higher error rate in replication 
[19]. 
The disadvantage of the mutator strains is their slow growth rate, as they have a 
doubling time of 90 – 120 minutes [15; 16]. In addition, the instability of the 
mutator genome renders long-term maintenance and storage troublesome. From 
protein engineering point of view, as the mutations are not limited only to the 
target gene, additional unwanted mutations may generate false positive signal to 
appear in the following screening step or mask the beneficial effect of a 
favourable mutation. 
2.1.1.3 Mutagens 
Before the discovery of PCR techniques random mutations were induced by 
exposing cells to mutagenic conditions. Random mutagenesis by mutagens is still 
used in strain development when adapting strains to cultivation conditions [20] or 




increasing yields of valuable substances [21]. The list of used mutagens is long 
and diverse including nitrous acid [22], sodium bisulfite [23; 24], methoxylamine 
[25] and hydroxylamine [26], to mention some, but the most popular methods in 
biotechnology are irradiating a strain with ultraviolet light [20], and exposing 
cells to alkylating agents such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG 
or NTG) [27] or ethyl methanesulfonate (EMS) [21; 28]. 
A practical point of view is to classify the mutagens according to the mechanism 
of action. Intercalating agents such as proflavin and acridine compounds cause 
predominantly frameshifts [29], which are seldom beneficial in gene engineering. 
More useful are different kinds of base modifications resulting in base pair 
substitutions. Alkylating agents MNNG and methyl methanesulfonate (MMS) are 
directly mutagenic by transferring methyl-groups on the bases found in dsDNA. 
For example, O6-methylguanine favourably base pairs with thymine and O4-
methylthymine with guanine, causing G-C to A-T and T-A to C-G transitions, 
respectively [30; 31; 32]. Also ethylating agents, such as EMS, cause the same 
mispairing, and the mutagenic potency of the three substances increases in the 
order MMS>MNNG>EMS, correlating with the ability to alkylate the O6 atom 
of the guanine base [33; 34]. Secondary mutations are also possible with 
alkylating agents through the launch of the error-prone SOS response [35].  
The non-alkylating chemical mutagens hydroxylamine and methoxylamine 
induce base substitutions through altered base paring in the same way as EMS 
and MMS, but without bulky side chains. Hydroxylamine and methoxylamine 
modify cytosine and adenine to N-hydroxy- and N-methoxy-derivatives [36] of 
which, for example, N6-methoxyadenine pairs with uracil or cytosine depending 
on the tautomeric form [37; 38]. 
The loss of the primary amine group of cytosine by deamination is a natural 
phenomenon with a half-life of 200 years on single-stranded DNA (ssDNA) and 
20 000 – 30 000 years on double-stranded DNA (dsDNA) [39; 40]. Deamination 
results in the formation of uracil, which preferably forms a base pair with 
adenine causing a C-G to T-A transition [4]. The deamination rate is enhanced by 
nitrous acid [22; 41], bisulfite [42], and UV irradiation [40]. The methylation of 
cytosine residues accelerates deamination tenfold and as the deaminated form of 
5-methyl-cytosine is the standard base thymine, the change remains undetected 
by the deamination control surveillance centered around uracil detection [43]. 
Bisulfite converts cytosine, but not 5-methyl-cytosine to uracil [44] and, 
therefore, instead of mutagenesis, it has found major use as a tool for mapping 
methylation sites in genome research [45]. Nitrous acid also deaminates adenine 
into hypoxanthine, which forms a base pair preferably with cytosine causing A-T 
to G-C transition [46]. 
High-energy ionizing radiation such as X-rays, γ rays and α particles are 
notorious for their ability to damage DNA, but as they may cause danger also to 
the operator, they are rarely used in biotechnological applications. Instead UV 
light is a very popular tool to induce random mutations. UV induces the 
formation of a pyrimidine dimer, which can lead to transitions, transversions, 




frameshifts and deletions due to mispairing or due to errors in subsequent repair 
response [47]. Although a TT dimer is the most abundant aberration induced by 
UV [48], it only rarely causes mutations as DNA polymerase preferably 
incorporates A opposite a damaged strand [49]. Because of the inherent A-rule of 
the DNA polymerase, a CC dimer is frequently changed to a TT dimer. Single C-
to-T transitions are encountered as well due to the accelerated deamination rate 
of cytosines in cyclobutane, i.e. CC dimer, structures [40]. Another mechanism of 
mutagenesis is that UV radiation generates free radicals, which oxidate guanine 
to 8-oxo-guanine, which in turn is able to pair with adenine inducing G-C to T-A 
transversion [50]. However, G-to-T transversions are not very common compared 
to C-to-T transitions [51]. 
As already highlighted, different mutagens cause different kinds of changes in 
DNA (Table 1). Higher efficiency mutagenesis and more diverse changes in 
DNA sequence are achieved by method combinations. For example, a base 
excision repair deficient E. coli strain is significantly more sensitive to nitrous 
acid than the wild-type strain [52]. Both simultaneous and sequential 
mutagenesis methods have been applied to develop production strains in the 
desired direction [53; 54]. Even the implementation of four sequential 
mutagenesis treatments was reported consisting of UV, low-energy ion beam, 
atmospheric pressure non-equilibrium discharge plasma, and exposure to MNNG 
in a study to increase the cellulase production in a Trichoderma viride strain [55]. 
The power of chemical mutagenesis can be further augmented by genome 
shuffling, in which beneficial mutations from different parental genotypes are 
brought together via protoplast fusion [56]. 
The benefit of chemical and physical mutagens is that no prior knowledge of the 
genetics of the trait to be improved is needed for mutagenesis. Some traits may 
need simultaneous modification of several genes, which may have very complex 
interaction networks with each other. In random genome mutagenesis all genes 
are equally exposed to the mutagens. These agents are simple to use and 
economically feasible to any laboratory. There are however many limitations in 
these techniques. Some mutagens, e.g., MNNG, MMS, EMS, and UV, are 
effective directly in vivo but others, e.g., hydroxylamine [26], bisulfite [42], and 
nitrous acid [22], can be used only with extracted DNA. Different species may 
also respond differently to the same mutagen. For example, a UV dose at 80 J/m2 
destroys over 99.9% of treated E. coli cells, but less than 20% of cyanobacteria 
cells of the Anabaena genus [57]. 




Table 1. Examples of chemical mutagens. 
Mechanism Representative agent Typical mutation 
Cell 
penetration 
Intercalation Acridine orange Frameshift Yes 




Methoxylamine A-T to G-C No 
Deamination Nitrous acid 
C-G to T-A &  
A-T to G-C 
No 
Dimerization UV irradiation C-to-T & CC-to-TT Yes 
2.1.1.4 Error-prone reactions with thermophilic enzymes 
Chemical mutagenesis is exerted on the whole genome in intact cells or on the 
extracted transformable DNA element in vitro. Most often variants of only a 
single gene are desired in protein engineering, which is difficult to achieve with 
chemical mutagens. There are some reported attempts to restrict the effect of the 
mutagen to a preselected stretch of DNA. In one technique published as “Dual 
Approach to Random Chemical Mutagenesis” EMS mutagenesis of a plasmid 
was followed by a restriction enzyme digestion to cleave the target gene, after 
which it was inserted into a fresh vector for transformation [58]. In another study, 
sodium bisulfite treatment of a template was combined with a PCR to amplify the 
target gene containing novel mutations for cloning into a new vector [59]. These 
are interesting approaches, but still rare examples in the modern times dominated 
by error-prone PCR. 
In error-prone PCR (epPCR), as the name implies, the fidelity of DNA synthesis 
is intentionally decreased. The error rate of the naturally 3´-5´ exonuclease-
deficient, i.e. non-proofreading, Taq DNA polymerase is 2.0 x 10-5 per nucleotide 
per cycle, which is tenfold higher than the error rate of Pfu DNA polymerase (1.6 
x 10-6 per nucleotide per cycle), latter of which is often preferred in molecular 
cloning because of its higher fidelity [60]. Due to these reasons the early epPCR 
development was centered on Taq DNA polymerase. The easiest way to decrease 
fidelity is to add Mn2+ which reduces base pairing specificity [61]. A 25-fold 
increase in error rate was documented by adding 0.7 mM MnCl2 in a 




polymerization reaction catalyzed by E. coli DNA polymerase I [61], and a 
similar phenomenon has been observed and widely applied in PCR reactions. 
Changing the stoichiometric proportions of dNTPs is another simple way to 
increase misincorporation. Biased dNTP pools are often used in combination 
with MnCl2 [62; 63] and, therefore, no exclusive report exists on the true effect 
of MnCl2 on Taq DNA polymerase fidelity. Instead, the combination of MnCl2 
with different stoichiometric proportions of dNTPs has been a subject of vivid 
discussion in the field of protein engineering [63; 64; 65], the debated issues 
being the frequency and quality of the mutations.  
There is a distinct bias in the type of errors naturally produced by Taq DNA 
polymerase. Pyrimidine-purine mismatches are more readily incorporated than 
pyrimidine-pyrimidine or purine-purine mismatches, which is a universal bias in 
both family A (e.g., Taq DNA polymerase) and family B (e.g., phi29 DNA 
polymerase) DNA polymerases, leading to a dominant share of transition 
substitutions [66; 67]. In a nonerror-prone PCR with Taq polymerase and 1 mM 
dNTPs, the transitions-to-transversions-ratio (Ti/Tv) was 2.6 [66]. In pro-
mutagenic conditions containing 20 µM of each dNTP and 0.25 mM MnCl2 the 
mutagenesis frequency was doubled from the initial 0.0008 to 0.0017 mutations 
per nucleotide per reaction (mut/ntR), although the Ti/Tv-ratio was essentially 
unaltered (2.9) [68]. A closer scrutiny of the individual substitutions revealed that 
two of the four possible transition mutations, namely A-T to G-C and T-A to C-
G, covered 63.2% of all mutations and the lowest frequency transversions, G-C 
to C-G and C-G to G-C, were present only with a 1.4% share [68]. 
A study on the effect of nucleotide imbalances on the fidelity of T4 DNA 
polymerase replication had a major influence on the use of high dGTP/dATP-
ratio to promote mutagenesis [64]. In this early and excellent study the 
occurrence of a substitution was deciphered from the reversion of a non-infective 
phenotype of Φ-X174 bacteriophage back to infective in a non-supressor E. coli 
strain by abolishment of an amber stop codon. Unfortunately, the assay was able 
to respond to T-A to C-T and A-T to G-C substitutions, but not to the occurrence 
of C-G to T-A and G-C to A-T transitions. The latter transitions could not be 
recorded, because there is no C in TAG codon and because changing G for A 
generates the ochre stop codon TAA. 
Against this background it is understandable that epPCR was reported to have 
been used with dATP/dTTP/dCTP/dGTP concentrations 0.2/1/1/1 mM with a 0.5 
mM MnCl2 supplement resulting in 0.0137 ± 0.0029 mut/ntR [63; 65], although a 
fairly similar mutation rate of 0.0085 ± 0.0043 mut/ntR was achieved with 
dATP/dTTP/dCTP/dGTP concentrations 1/1/1/0.2 mM [63], a ratio which is 
exactly the opposite of the earlier recommendation of high dGTP/dATP [64]. 
Naturally, precaution is needed when comparing mutation frequencies per 
reaction across studies as the frequency is dependent on the number of cycles 
implemented. The major difference between the high dGTP/dATP and high 
dATP/dGTP is the Ti/Tv-ratio, which was the usual 2.7 in the former and only 
0.4 in the latter case. The authors of these findings argumented, however, that the 




high dATP/dGTP-ratio resulted in a strong mystical bias for substituting A in the 
template for something else (not shown in detail) and hence, for balanced 
mutagenesis dATP/dTTP/dCTP/dGTP concentrations of 0.2/1/1/0.2 mM were 
recommended with a Ti/Tv-ratio of 0.8 and a mutagenesis rate of 0.007 mut/ntR 
[63]. After all, avoiding an excess of dGTP is crucial as it seems that the 
predominant transitions are directly linked to the G:T mismatch. 
In a reported epPCR method titled “hypermutagenic PCR”, a 100-fold increase in 
mutation frequency was obtained by pushing the dNTP bias a bit further in a Taq 
DNA polymerase driven reaction with 0.5 mM MnCl2 with 30 µM dATP, 1 mM 
dTTP, 30 µM dCTP and 1 mM dGTP [62]. The enhancement of the mutation rate 
from 0.001 to 0.1 mut/nt was dependent on the addition of MnCl2, but there were 
still more transitions than transversions with a Ti/Tv-ratio of 2.2 with two 
dominating mutations, A-T to G-C and T-A to C-G, accounting for 61% of all the 
changes. What was achieved with the high dGTP/dCTP-bias, not experimented in 
the earlier studies, was an increased bypass of the G:G mismatch from 0.7% [68] 
to 2.5% [62], which is claimed to be one of the most substantial blocks for the 
Taq DNA polymerase driven polymerization [69]. 
As a summary, with imbalanced dNTP pools it is possible to modify the 
mutational bias. A DNA polymerase with no bias would generate errors with a 
Ti/Tv-ratio of 0.5 due to four possible transitions and eight possible 
transversions. This ratio is hardly ever achieved with Taq DNA polymerase in 
any conditions, and biasing the dNTP pools to the extreme leads to low PCR 
product yields [63; 70]. Other methods that can be used to increase error rate are 
to add high doses of MgCl2, to change the pH, to overload DNA polymerase [71], 
and, naturally, to decrease the template amount and to increase the number of 
cycles in PCR. 
Due to the error preferences of Taq DNA polymerase for A-to-T and T-to-A 
transversions (and transition mutations in general) adenosine and thymidine 
nucleotides are four times more likely to be mutated compared to guanosine and 
cytidine [72]. This skew was targeted with a modified Pfu DNA polymerase 
lacking the 3´-5´ exonuclease domain [73]. The preferences of this enzyme called 
mutazyme DNA polymerase are opposite to Taq DNA polymerase as it mutates 
guanosine and cytidine nucleotides three times more frequently than adenosine 
and thymidine [73]. Logically, to achieve a more balanced mutagenesis the two 
error-prone enzymes were combined in the newest mutazyme-containing 
commercial formulation [74]. 
Mutazyme (exonuclease-deficient Pfu DNA polymerase) exhibits a 40-fold 
higher error rate than the native enzyme with transitions as the main substitution 
type [73; 75]. The processivity of the Mutazyme is increased in the commercial 
formulations by adding a polymerization enhancing factor in the reaction [76]. 
The major polymerization enhancing factor of Pfu is a protein called P45, which 
is a dUTPase that catalyses the degradation of dUTP to dUMP and 
pyrophosphate [77]. The degradation of dUTP enhances productivity, because 




most thermophilic DNA polymerases are inhibited by uridine containing template 
DNA [78; 79]. 
Another route to decrease the fidelity of an error-prone DNA polymerase is to 
genetically modify the dNTP binding site of the polymerase. In one study, the 
proof-reading ability of Pfu DNA polymerase was first abolished with a point 
mutation D215A in the exonuclease domain, after which another mutation, 
D473G in the dNTP binding site, increased the error rate to 7 x 10-4 per 
nucleotide per cycle, which is 500 times higher than in the wild type [80]. By 
comparison to the exonuclease-deficient enzyme and Taq DNA polymerase 
reactions in modified reaction conditions, the double mutant was claimed to 
produce the most unbiased set of random mutations [80]. In addition to Pfu DNA 
polymerase, the fidelity of Taq DNA polymerase has been genetically 
engineered, and a single substitution in the dNTP binding site resulted in over 20-
fold higher error rate in PCR compared to the wild type [81]. 
Nucleotide analogs may also be used to produce random mutations in a DNA 
polymerase catalyzed reaction. Especially the 5'-triphosphate of 6-(2-deoxy-b-D-
ribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-C][1,2]oxazin-7-one (dPTP) and 8-
oxo-dGTP are efficiently incorporated by Taq DNA polymerase with distinct 
mutation profiles [82]. P is a bicyclic base analogue, which pairs with adenine or 
guanine creating transition mutations [83]. 82% of the dPTP-generated mutations 
in an epPCR reaction with Taq DNA polymerase were A-to-G and T-to-C 
changes that arise from the preferential incorporation of dPTP opposite adenosine 
and subsequent pairing with an incoming dGTP [82]. While only 17% of 
mutations were G-to-A and C-to-T mutations, altogether transitions covered over 
99% of all the observed mutations showing the high selectivity of the P base 
pairing. 8-oxo-dGTP induced only transversions of which T-to-G and A-to-C 
changes covered 98% of all the mutations arising from the misincorporation of 8-
oxo-dGTP opposite adenine which upon replication is substituted with cytosine 
[82]. 
A combination of base analogs dPTP and 8-oxo-dGTP would balance the 
mutational outcome. However, when this strategy was implemented, the mutation 
profile mostly resembled pPTP fingerprint due to the lower incorporation 
efficiency of 8-oxo-dGTP [82]. There are also other base analogs that have been 
used in mutagenesis, e.g., dITP [84], N4-amino-dCTP [85], 2-OH-dATP [86] and 
2-OH-dGTP [87], but the reported mutagenesis frequencies in Taq DNA 
polymerase driven PCR (mut/ntR) with these analogs are less than 1/10 of the 
mutagenesis frequencies obtained with dPTP and 8-oxo-dGTP [84; 86; 87]. 
Technically more complicated variations of mutagenesis by thermophilic DNA 
polymerase have also been developed. One of them, called SeSaM, begins by 
shearing template DNA into ssDNA fragments [88]. Shearing is achieved by 
synthesizing template DNA in the presence of thiol-modified dGTP (dGTPαS), 
followed by iodine treatment cleaving the sugar-phosphate backbone at the sites 
of the sulfur [88]. Terminal deoxynucleotide transferase catalyses the extension 
of the ssDNA fragments with one or several universal nucleotides, e.g., dPTP, 




that are subsequently used as megaprimers and extended to full-length genes [88; 
89]. At the end of the process, the universal bases are replaced by natural bases in 
a final PCR reaction. The advantages of the SeSaM-method are the increased 
rates of transversion and semi-controlled mutagenesis of consecutive bases, the 
latter being a rare event in conventional epPCR. The general methods for 
increasing error rate in PCR are summarized in Table 2. 
Table 2. Common procedures for increasing error rate in PCR. 
Method Reference 
Imbalanced dNTP pools [62], [63], [68], [65]  
Mn2+ supplementation [62], [63], [68], [65] 
Modified DNA polymerase [73], [80], [81] 
Nucleotide analogs [82], [84], [86], [87] 
Less template, more cycles common knowledge 
2.1.1.5 Error-prone reactions with mesophilic enzymes 
There are DNA polymerases in higher eukaryotes, which are error-prone by 
nature. Human DNA polymerase β belongs to the family X of DNA polymerases 
and is involved in the base excision repair pathway in man [90]. As it produces 
10-3 to 10-4 mutations per nucleotide [91], in one study, random mutations were 
introduced into antibody genes with a single pass of replication with DNA 
polymerase β [92]. In a later study, another naturally error-prone human DNA 
polymerase was used to randomize an amylosucrase gene [93]. The employed 
enzyme, DNA polymerase η (eta), belongs to the DNA polymerase family Y that 
exhibit the highest error rates ever recorded of naturally occurring DNA 
polymerases, namely 10−1 to 10−3 mutations per nucleotide [94]. Y-family 
polymerases are involved in translesion synthesis in man and do not possess any 
proof-reading activity [95]. 
Comparison of the mutagenesis frequency obtained by the human DNA 
polymerases β and η correlate well with their informed fidelity as 2 x 10-3 and 1 x 
10-2 mutations per nucleotide were obtained by a single pass of replication, 
respectively [93]. Following this line of reasoning, the most bizarre human DNA 
polymerase candidate for mutagenesis is the DNA polymerase ι (iota), a Y-family 
member, which misincorporates guanosine and thymidine opposite a template 
thymidine with much higher efficiency than adenosine resulting in almost total 




degradation of genetic information [96]. Human DNA polymerases produce a 
similar bias for transition mutations as observed with Taq DNA polymerase. In 
addition, DNA polymerase η generated deletions at a rate of 6.7 × 10−4 per 
nucleotide which, on average, corresponds to more than one frameshift per 2 kb 
gene [93]. Furthermore, an E. coli strain with a decreased fidelity of replication 
was developed, containing targeted mutations in DNA polymerase I, to be used 
as a mutator strain [97]. 
The naturally high error rate of the RNA replicase of Qβ bacteriophage has also 
been exploited in gene diversity generation [98].  Mutation rates of 7 x 10-2 per 
nucleotide were recorded in exploring the capability of Qβ RNA replicase [98], 
which were close to the error rates of the most low fidelity human DNA 
polymerases. The spectrum of substitutions was also more even with Qβ RNA 
replicase than with conventional epPCR, with an equal presentation of all 
transversions contrasted by epPCR, which favoured changing A and T over G and 
C. However, also Qβ RNA replicase showed a strong transition bias for A-T to 
G-C [98]. Another group of polymerases with high error rate are the reverse 
transcriptases that have also been exploited to incorporate base analogs [99]. 
Error-prone RCA is an isothermal DNA amplification method to generate 
random mutations in circular DNA by lowering the fidelity of phi29 DNA 
polymerase [100]. When RCA was carried out in the presence of 1.5 mM MnCl2 
0.0035 mut/ntR were obtained [100], which is a lower frequency than reported 
for epPCR. The benefit of epRCA is the simplicity as a plasmid of interest can be 
directly amplified in error-prone conditions and transformed to a new host as a 
DNA concatemer [100]. The efficiency of direct concatemer transformation is 
low, but it can be easily increased 10- to 50-fold by cutting the concatemer into 
plasmid-sized units and re-circularizing the product with a ligase, or by 
implementing Cre/loxP recombination [article II]. The drawbacks of epRCA are 
that, by default, the whole plasmid is mutated in addition to the gene of interest. 
MnCl2 decreases the product yields, and there is a strong bias for C-G to T-A 
mutations covering 66% of all mutations with a Ti/Tv-ratio of 2.7 similar to Taq 
DNA polymerase [100]. 
2.1.1.6 Transposons 
Some transposons, e.g., mini-Mu, are randomly integrated into a target DNA 
[101]. A method called trinucleotide exchange mutagenesis (TriNEx) is based on 
a modified mini-Mu transposon carrying type IIS restriction enzyme sites, which 
are used to cleave off the integrated transposon from the template sequence with 
three extra nucleotides leaving blunt ends [102]. The gap is repaired with a DNA 
cassette carrying a kanamycin resistance gene, the new randomized codon to be 
inserted and a pair of type IIS restriction enzyme sites. After antibiotic selection 
and DNA purification, the kanamycin resistance gene is cleaved off and the 
backbone, with the new extra codon, re-circularized. Other very similar 
mutagenesis methods based on the random insertion of a transposon carrying 




type IIS restriction enzyme sites for subsequent manipulation to delete or insert 
DNA have also been reported [103; 104]. The main benefit of random 
mutagenesis by transposons is the ability to change nucleotides in consecutive 
positions, which rarely occurs with other random mutagenesis methods. Trimer 
mutagenesis by TriNex results in an exchange of a single codon and double 
codon in 1/3 and 2/3 insertions, respectively, which may be even more than 
desired in some applications. 
2.1.1.7 Choosing the method 
There is plenty of information available on the characteristics and potency of 
especially in vivo mutagens [105], and the full picture of the effects is becoming 
more and more exact with whole-genome sequence analysis [106; 107]. 
However, there are only few comparative studies on the efficiency of different 
random mutagenesis methods in producing mutations for directed evolution 
experiments. According to one report comparing XL-1 Red strain, 
hydroxylamine and epPCR methods in lacZα mutagenesis, the sequence of 
increasing mutation frequency was hydroxylamine > XL-1 Red > error prone 
PCR [108]. In particular, epPCR with nucleotide analogs 8-oxo-dGTP and dPTP 
provided the highest frequency of mutations along with the best control over the 
mutation load by altering analog concentrations. Like already discussed above, 
most mutagenesis methods have a bias for transitions over transversions, which 
is especially valid with dPTP, 8-oxo-dGTP and hydroxylamine [108]. For a more 
balanced mutagenesis, a combination of methods is advisable. There are also 
computer programmes available to model the impact of the chosen method(s) on 
the anticipated diversity at the protein level [109; 110]. The main issues 
restricting the method selection are whether in vivo or in vitro mutagenesis is 
preferred and whether the target of mutagenesis is known. Other aspects are the 
available time frame for mutagenesis and the aspired complexity of mutations, 
e.g. changes at neighbouring codons or consecutive bases. Some characteristics 
of the random mutagenesis methods are summarized in Figure 2. 






Figure 2. Characteristics of random mutagenesis methods. The frequency and 
the complexity of mutations introduced into DNA molecules can be increased 
with various methods. Error-prone enzyme reactions and transposons result in 
the highest clonal diversities in a short time, whereas the advantage of in vitro 
mutagens and mutator strains is the fairly simple implementation. Ti: 
transition. 
2.1.2 Oligonucleotide-directed mutagenesis 
2.1.2.1 Focused random mutagenesis and doped oligonucleotides 
Above, epPCR was discussed for random mutagenesis of full-length genes, but 
naturally, epPCR can be directed to a specified shorter region by using primers as 
delimiters. A practical application is to randomly mutate a single domain of 
interest instead of the whole gene. The challenge in this approach is how to 
incorporate the randomized domain segment to be part of the gene replacing the 
invariant sequence. This is most often accomplished by inserting complementary 
sequence parts or restriction enzyme sites at the ends of the segment to be 
inserted [article I; 111]. There are numerous techniques available to incorporate 
















































“Construction of highly diverse libraries” and “Construction of small diversity 
libraries”. 
The first site-directed mutation was documented in 1978, when Dr. Smith et al. 
altered the sequence of a DNA oligomer at the synthesis phase and incorporated 
the oligomer into a gene by primer extension mutagenesis [112]. The obvious 
consequence from this invention was that by providing mixtures of nucleotides to 
the growing polymer at the solid-phase synthesis, several variants could be 
created simultaneously. Nowadays, sequence-specific randomization of one or 
several positions in a DNA oligomer is a routine operation. If the nucleotides are 
provided at unequal proportions to favour the wild-type sequence, the diversified 
oligonucleotides are termed “doped”, whereas equal mixture of all four bases 
would be referred to simply as a random oligonucleotide. 
The first doped oligonucleotide dates from the year 1983 and it contained nine 
consecutive positions that were synthesized in the presence of 75% wild-type 
nucleotide and 8% of each of the other three nucleotides [113]. After the 
synthesis of another complementary doped oligonucleotide, the two 
oligonucleotides were hybridized with each other and ligated to a restriction 
enzyme site. In comparison to a totally random strategy, a limited number of 
variants are created by the doped oligonucleotide strategy with most of the 
members still retaining some of the parental character. 
The major benefit of using doped oligonucleotides is the ability to introduce 
transitions and transversions in a site-specific manner even at sequential 
positions. Doped oligonucleotides are an effective alternative, when a short 
stretch of DNA is to be extensively mutated at various positions [114] and in 
discovery research related to noncoding sequences [115]. Oligonucleotides with 
equal stoichiometry of mixed bases per site can be ordered from most suppliers 
with the same price as a single base, but extra costs are added when ordering 
oligonucleotides with unequal base mixtures. The incorporation of a diversified 
oligonucleotide pool into the gene of interest results in a library containing 
mutations only at the site of the oligonucleotide. Full-length gene variants with 
evenly distributed mutations can also be assembled in vitro with modern 
assembly techniques by designing synthetic doped oligonucleotides with 
overlapping sequences [116; 117]. 
2.1.2.2 Oligonucleotides with randomized codons (NNN/NNK/NDT/KMT) 
When the aim is to study protein variants, it is far more useful to design the 
library randomization codon-by-codon than base-by-base. The site-directed 
mutagenesis methods differ in this respect (Figure 3), and there are several 
solutions for codon-wise mutagenesis, which will be discussed in the next 
section. The degenerate codon NNN covers all 20 amino acids, but also three 
stop codons. With a single NNN codon, truncated protein variants are created at 
4.7% probability if no skewing occurs due to technical aspects. This can be 




avoided by using degenerate codons NNS or NNK (S = C or G and K = G or T), 
which also code for all 20 amino acids, but only for one stop codon. The 
reduction of the all-in 64 codons to the chosen set of 32 codons has significant 
implications, when several residues are diversified in the same gene. The 
likelihood of obtaining a stop codon in a gene exceeds 50% after ten sequential 
NNN codons, but with NNS (or NNK) only after sixteen codons. 
 
Figure 3. Site-directed diversification techniques. Arrows indicate a shift from 
base- to codon-wise randomization and, therefore, towards more controlled 
changes in the polypeptide sequence. 
An even more central question for equal presentation of amino acid residues at a 
certain position in a library is how to cope with the codon redundancy. 
Tryptophan and methionine are coded by a single codon whereas arginine, 
leucine and serine are represented in the genetic code by six codons. The 
NNS/NNK-randomization is beneficial also in this respect as it narrows the gap 
between the most redundant and least redundant codons from 6:1 to 3:1 (Figure 
4). For achieving a more balanced set of amino acid residues by incompletely 
defined bases, some amino acids must be excluded from the library design. A 
very attractive alternative to NNK is NDT, which is encoding twelve amino acids 
by twelve codons. This set includes a representative residue of each chemical 
subgroup characterized by a small (glycine, serine), hydrophobic (leucine, 
isoleucine, valine), aromatic (tyrosine, phenylalanine), acidic (aspartate), and 
basic (histidine, arginine) side chain including cysteine and asparagine having a 
thiol- and amide-group, respectively.  
The advantage of NDT over NNK degeneracy is that it enables the exploration of 
a more diverse structural and functional sequence space with the same number of 
library variants [118]. For example, a 95% coverage of the structural diversity 
encompassed by eight consecutive NNK codons (theoretical size: 1.0 x 1012 
variants) requires sampling of 3.3 x 1012 clones, but only 1.3 x 109 clones need to 
be screened to explore the structural variants generated by eight consecutive 
NDT codons (theoretical size: 4.2 x 108 variants) [118]. The practical difference 
between these two scenarios is that for display systems requiring bacterial 
transformation, a billion transformants is manageable [article I; 119], but a 














Smaller degenerate codon repertoires have also been exploited for library build-
up especially in the field of synthetic antibodies. The diversification of the heavy 
chain CDR-loops at a total of 18 positions with a degenerate codon KMT coding 
for tyrosine, alanine, aspartate and serine, and subsequent selections with phage 
display resulted in antibodies with nanomolar binding affinities [120]. In a 
continuation study, the reduction of the tertiary code KMT to a binary code TMT 
pointed out that sufficient structural diversity is harnessed with a minimal choice 
between tyrosine and serine for selecting antigen-specific antibodies [121]. 
Especially tyrosine was pointed out to be a key residue for mediating molecular 
contacts [122]. 
 
Figure 4. Reduction of genetic code with incompletely defined bases for 
generation of binding interfaces while maximizing the retention of structural 
and functional diversity. By a careful selection of the allowed codons in the 
target position, a more balanced presentation of functionally different amino 
acids is achieved. 
2.1.2.3 Defined primer pools, TRIM and beyond 
Often, it is not possible to cover the optimal set of amino acid diversity with a 
single degenerate codon consisting of incompletely defined bases. One solution 
is to synthesize each oligonucleotide separately with a defined sequence and pool 
them afterwards for implementation. Technical proceedings in massively parallel 
DNA synthesis are making this approach more and more attractive. For example, 
in one study exploring the limits of a programmable parallel oligo synthesizer, 53 
478 unique sequences of ~ 100 nucleotides in length were successfully 




synthesized on 23 glass slide arrays [123]. The synthesized oligonucleotides can 
be detached from the solid support and rendered for further manipulation in vitro 
or cloned forward to biological systems [123; 124]. Naturally, defined diversity 
pools still suffer from a low success rate of perfect oligonucleotides, which varies 
from 21 to 58% per slide [123]. The majority of the rest of the oligonucleotides 
contain one or more base substitutions [123], which is necessarily not a 
disadvantage from the directed evolution point of view.   
Full control of the combinatorial amino acid diversity is obtained by performing 
oligonucleotide synthesis with trinucleotide phosphoramidites instead of the 
conventional nucleoside phoshoramidites [125; 126]. In trinucleotide 
mutagenesis (TRIM) a single codon is used to code for each amino acid and for 
each residue position, the preferred codons are mixed in desired proportions for 
integration into the growing oligonucleotide chain (Figure 5). This is the method 
of choice for very complex libraries, such as universal antibody libraries, in 
which diversity exceeds the sampling capacity emphasizing the importance of 
library quality [119; 127]. 
There are also other techniques for trimer mutagenesis taking advantage of 
enzymatic reactions. One mature technology is called slonomics, which is based 
on the use of IIS restriction enzymes and self-complementary hairpin-looped 
DNA oligonucleotides (Figure 5) [128]. For the synthesis of all possible 
sequences, an array of 4096 solid-phase-tethered anchor oligos and 64 
dispensable splinker oligos are needed. The synthesis of a particular sequence 
starts with an anchor oligonucleotide containing the last six bases of the target 
sequence, of which the very last three nucleotides are present as a 5´-protruding 
trimer. A splinker oligonucleotide containing a compatible 5´-protruding trimer is 
annealed and ligated to the anchor, forming a double-stranded double-hairpin 
fragment, which is subsequently digested with an anchor-specific IIS type 
restriction enzyme releasing the splinker. At cleavage the splinker 
oligonucleotide obtains an extra trimer at both the 5´- and the 3´-end of the 
hairpin loop. The released elongated splinker is ready to be annealed to a second 
anchor containing the next six nucleotides to be incorporated corresponding to 
the ninth last to the fourth last nucleotide of the target sequence. Blocks of 18 bp 
are produced in a single synthesis, and these are then assembled into longer 
fragments. So far, slonomics has been applied, for example, to the construction of 
a gene library of G protein coupled receptors for finding variants with increased 
stability [129]. 
There is yet another older technique, termed MAX randomization or selective 
hybridization, for integration of desired trimer pools (Figure 5) [130]. A single-
stranded template oligonucleotide is first synthesized with degenerate codons 
NNN at the sites of diversification. Then selection oligonucleotides containing 
six template-complementary bases at the 5´-end and three bases coding for the 
desired amino acid at the 3´-end are let to hybridize to the NNN-template. In a 
following ligation step, only the perfectly annealed selection oligonucleotides are 
ligated to each other. The formed ligation product is selectively amplified in a 




PCR to copy the restricted diversity forward. For the total coverage of 20 amino 
acids, 20 separately synthesized selection oligonucleotides are needed for each 
NNN-position. Each NNN position also requires a separate set of homing 
oligonucleotides. Other technical limitations compared to the TRIM and 
slonomics are that several sequential diversified codon positions cannot be 
managed and that the reagents are not universally applicable to other targets. 
 
Figure 5. Techniques for codon-wise diversification. The most straight-forward 
approach is to synthesize each desired variant individually in parallel (defined 
diversity), whereas the most common approach for codon-wise diversification 
is to directly add trinucleotides to the growing chain in the synthesis phase 
(TRIM-oligos). One variation of the trimer approach is to use programmable 
robotic platform that operates on 4096 arrayed anchor oligos, each of which, 
passes three nucleotides both from its 5´- and the 3´-end on a growing splinker 
hairpin (slonomics). Slonomics takes advantage of the catalytical mechanism of 
a IIS restriction enzyme that cuts DNA outside of its recognition sequence. 
Upon digestion, the splinker is released and transferred to other wells in the 
array for the uptake of the next nucleotides. The least applied method for 
codon-wise diversification is to use a ssDNA molecule as template containing 
regions of fully randomized sequence (NNN) at the target positions (MAX 
randomization). Selection oligos with defined sequences (and desired 
trinucleotides at the 3´-end) are let to hybridize to the template. The correctly 
ligated dsDNA stretches contain combinations of only the desired codons. 




2.1.2.4 General considerations of DNA incorporation 
There is a wide range of methods for integrating diversified DNA elements into 
full-length genes for testing the library function at the protein level. Instead of 
listing all published methods, of which several are duds due to a lack of users, 
attention is given here to the methods with most impact. In addition, as the 
requirements for the size of a gene variant library vary according to the 
application, techniques for creating a large or a small library are discussed in 
separate sections. From a practical point of view, the proposed division into 
small- and large-scale methods is justified. The division is clear by a careful 
scrutiny of the reported size and quality of the established libraries, irrespective 
of the theoretical calculations. 
From a theoretical point of view, the division of methods, as suitable for large- or 
small-scale library creation according to the extent of randomization and the 
number of obtainable library members in vivo, is subjective as several parameters 
affect the judgment. An exactly equivalent experimentation has rarely been 
applied for an objective comparison of libraries constructed with different 
methods. Another factor to be considered is DNA transformation, which is more 
efficient into E. coli than to Bacillus subtilis or yeast Saccharomyces cerevisiae. 
There are also major differences in the transformation efficiency of E. coli 
depending on the strain and method, e.g. heat shock vs. electroporation [131; 
132]. Smaller circular DNA constructs transform with higher efficiency than 
larger ones [131]. Cell-dependent display systems require transformation of self-
replicating or genome-integrating DNA, whereas cell-free display systems 
function directly with short linear DNA fragments [133]. For these reasons, only 
library construction methods for cell-dependent display systems with an 
emphasis on libraries hosted by E. coli are discussed in the following paragraphs. 
The library construction methods can be evaluated according to several technical 
parameters. Wild-type gene copies are generally unwanted in the final library, 
because their presence reduces the diversity of the library. Wild-type copies may 
also cause a trouble in the selection and, therefore, template background is an 
important parameter to consider, when pondering between different construction 
methods. A second parameter is the frequency of unintended display-impairing 
mutations that inevitably lower the quality of the library. Typically, these are 
insertions or deletions leading to frameshifts or substitutions in the conserved 
regions causing misfolding and hence, the loss of function. The total number of 
obtained library members is a third useful parameter. Not only is the number of 
unique clones important, but also the relative frequencies of the members in the 
library. If the unique members are present at very disparate proportions, it may be 
due to the unequal incorporation of the provided building blocks at the DNA 
synthesis phase, the defects in library assembly, or the bias arising post 
transformation. Naturally, the total lack of certain variation of the designed 
diversity is a more severe defect than biases in the diversity presentation. 




There are also other than technical issues to consider when choosing the 
appropriate library construction method. The commercial availability, the 
intellectual property landscape and the price may be important factors in decision 
making. Some methods require rare enzymes or custom synthesis services, which 
may not be easily accessible. A short hands-on time, simple protocols, 
reproducibility and scalability are also preferred characteristics of a library 
construction method. A very detailed analysis of these parameters in relation to 
each method is out of the scope of this review, but features of the utmost 
importance are discussed when relevant. 
2.1.2.5 Construction of highly diverse libraries 
Libraries exceeding one billion members are typically built to develop de novo 
binding functions that do not exist in the parent protein by randomizing surface-
exposed residues. The development of the “one fold, many functions” -concept 
originates from studies in adaptive immunology. Antibodies recognize various 
kinds of antigens, although all of them are based on the same β-sandwich fold 
[134]. The majority of the molecular contacts of an antibody responsible for 
antigen binding are provided by the surface exposed residues in the loops of the 
β-sandwich fold of the variable domains termed complementary determining 
regions (CDR) [134]. Later, other analogous biological systems have been found 
[135; 136], but not surprisingly, the majority of the large library undertakings so 
far are based on the immunoglobulin or other related scaffolds. 
It is logical to begin the scrutiny of the library build-up methods with examples 
from natural repertoires as similar methods have been applied at a later point in 
history to harness diversity from synthetic origin. The first universal, i.e. naïve, 
antibody library was constructed by amplifying rearranged variable light and 
heavy chain domain genes from B cells by PCR and joining them with a flexible 
linker for display [137]. Ever since, natural repertoires have been a popular 
source of antibody library diversity with a continuous flow of construction up-
dates of larger and larger repertoires [138; 139; 140; 141; 142; 143]. For 
example, in the latest Pfizer initiative mRNA of peripheral blood leukocytes 
originating from 637 human donors and 17 human spleen samples were reverse-
transcribed to cDNA and amplified with degenerate family primers to obtain 9 
VH, 7 Vκ and 9 Vλ chains [143]. The VL and VH genes were joined with an 
intervening glycine-serine-linker by PCR assembly creating VH-(Gly4Ser1)3-VL-
constructs, i.e. single chain variable fragments (ScFvs). SfiI restriction 
endonuclease sites were added at the 5´- and 3´-ends of the amplified ScFvs for 
cloning the ScFv gene repertoire into a phagemid for display [143].  
In the latest naïve library repertoire by Medimmune, cDNA from spleen 
lymphocytes and fetal liver was used as the source of diversity, and the amplified 
VH and VL repertoires were directly cloned into a display vector with unique 
restriction enzyme sites, instead of PCR assembly [144]. The achieved number of 
transformants of the Pfizer library was 3.1 x 1010 cfu and that of Medimmune 1.3 




x 1011 cfu by 310 and 200 parallel electroporations, respectively. In both cases 
the ligation mixture was electroporated into electrocompetent E. coli TG1 cells. 
Other groups have also reported construction of libraries with a comparable size 
of over 10 billion members mainly with PCR assembly and bimolecular ligation 
[119; 138; 139]. PCR assembly, known also as splicing by overlap extension 
(SOE-PCR) [145], is based on identical sequences at one end of the PCR 
products to be joined. During the annealing phase of thermal cycling, some of the 
single-stranded PCR fragments will hybridize with a neighbouring fragment, 
priming each other. At the extension phase, the two DNA strands are extended by 
DNA polymerase welding the two fragments into one piece (Figure 6). The most 
notable information of the PCR-assembled Pfizer library was the diversity 
assessment. The size of the primary library was estimated to be 3.5 × 1010 unique 
members by deep sequencing a sample covering 96 303 heavy and 98 946 light 
chain reads, which is a perfect match with the total number of obtained colonies 
in transformation [143], indicating that each colony harbours a unique 
clone. This finding is more or less valid also for other libraries assembled with 
the same method. 
PCR assembly has also been a popular method for construction of libraries with 
diversity integrated partly or fully from synthetic oligonucleotides [119; 146; 
147; 148; 149]. Although most synthetic repertoires have captured framework 
regions from template DNA, the construction of VL and VH domain libraries 
with over a hundred million members by synthetic ssDNA oligonucleotide 
assembly have been reported [150]. The ssDNA oligonucleotide assembly was 
accomplished by T4 DNA polymerase without PCR, which is a noteworthy 
distinction between this method and the ones described above. The final step in 
most PCR assembly projects is the insertion of the assembled cassette into the 
final display vector with restriction enzymes and ligase for transformation. 
Different methods may be employed with other hosts. For example in yeast 
library construction, a PCR-assembled cassette was successfully integrated into a 
yeast display vector by recombination in vivo [146]. 
Another construction method with a well-established record of libraries with over 
a billion members is the Kunkel mutagenesis [122; 151; 152; 153; 154]. This is a 
primer extension mutagenesis technique in which mutations are incorporated into 
the final transformable circular DNA without bimolecular ligation [155], which is 
the most significant difference to the methods described earlier. In Kunkel 
mutagenesis the temple gene is propagated on a phagemid in an E. coli strain 
lacking the uracil-DNA-glycosylase (UDG) and dUTP pyrophosphatase 
activities. Due to the two deficiencies, there is a low frequency of uracil bases in 
place of thymine in the template DNA. The presence of uracil can be exploited as 
a selection feature as uridylated DNA is biologically inactivated in a wild-type 
ung+ dut+ host [67]. 
For Kunkel mutagenesis, the template is obtained in single-stranded form from 
filamentous phage particles that have been passed through the host cells. A 
mutagenic primer, containing a template complementary sequence on both sides 




of the mutated region, is hybridized to the template and extended with a DNA 
polymerase around the phagemid. The remaining nick is sealed with a DNA 
ligase present in the enzyme blend. The end product is a covalently closed 
circular DNA, which is ready for transformation (Figure 6). As the product is a 
heteroduplex of a nascently synthesized mutated strand and the uridylated 
template strand, the nascently synthesized strand has a selective advantage over 
the template when the heteroduplex is propagated. Kunkel mutagenesis typically 
results in 50% mutagenesis efficiency [article I; 155]. In most library initiatives 
relying on Kunkel mutagenesis, the efficiency of the method is augmented by 
using templates containing stop-codons at the sites of diversification, which 
inhibits the display of the template protein [122; 152]. 
 
Figure 6. Methods for construction of highly diverse gene libraries. 
A more efficient way to improve Kunkel mutagenesis is to decrease the template 
background prior to transformation. In one solution, the single-stranded template 
was modified further at the site of diversification to contain a DNA hairpin loop 
forming a functional restriction enzyme site [154]. The digestion of the parental 
strand eradicated the replicative potential resulting in 95% mutagenesis 
efficiencies upon transformation. Another approach, which does not require any 
template sequence manipulation for template background reduction is called 
selective RCA [article I]. In this method, the heteroduplex is treated with UDG 
followed by rolling circle amplification. The resulting concatemer is resolved 
back to single plasmid units for transformation. The rationale behind this 
technique is that the abasic sites created by UDG hinder extension by phi29 DNA 




polymerase used in the subsequent RCA step. As a result, the nascently 
synthesized intact circular mutated DNA is selectively amplified. Another benefit 
of this technique is the ample supply of transformable DNA, which is a 
particularly lucrative feature for library build-up in yeast and mammalian cell 
display systems. 
A fairly infrequently encountered construction method in the field of large 
primary libraries containing defined diversity at chosen positions is cassette 
mutagenesis. In this method, site-directed diversity is created by conventional 
solid-support synthesis of oligonucleotides into one strand, which is then primed 
and extended into dsDNA by DNA polymerase [111]. The cassette is digested 
with a pair of unique restriction enzymes and the diversity, e.g., covering a single 
CDR loop, is inserted into a template gene replacing a stuffer. This method was 
practiced by the company Morphosys in the early library versions called HuCAL 
[111], HuCAL Gold [156] and HuCAL Platinum [127]. However, the CDR 
diversity in the latest version of the library called Ylanthia, being the largest 
repertoire of synthetic human antibodies in Fab-format with 1.3 x 1011 claimed 
members, was constructed with slonomics technology [157].  
As described above, slonomics is based on IIS type restriction and ligation for 
the sequential addition of nucleotide triplets to the growing dsDNA chain [128]. 
The synthesis of longer regions requires the assembly of short 18 bp blocks 
generated by the core technology. There is also another antibody library initiative 
by Pfizer containing slonomics-assembled CDR regions [158]. In both initiatives 
the final randomized CDR cassettes were inserted into the Fab framework with 
conventional restriction and ligation. After a full scale-up of the synthesis 
process, only 1 µg of heavy and light chain DNA was obtained by combination 
of slonomics and cassette assembly. For the final insertion of the Fab repertoire 
into the display vector, the heavy and light chains were joined by ligation and 
extensively amplified in 1000 parallel reactions by PCR to yield 100 µg of Fab 
cassette. As a result of 800 electroporations into TG1 cells, 4 x 1010 library 
members were obtained [158]. Diversity was well retained, despite the 
amplification, as only 1.5% of the CDR-H3 members were observed more than 
once in the transformed library by deep sequencing 740 000 domains [158]. 
Cassette mutagenesis requires extensive and careful design of template sequences 
to obtain a collection of unique restriction enzyme sites for entering diversity at 
several sites of a single gene. In addition, the efficiency of digestion and ligation 
of the formed cohesive ends varies from enzyme to enzyme hindering the 
workflow. In contrast, PCR assembly and Kunkel mutagenesis rely on the high 
and specific affinity of long stretches of complementary DNA sequences. The 
uracil excision-based ligation method, also known as USER cloning, shares 
common features with both the PCR assembly and Kunkel mutagenesis. In this 
method, PCR is carried out with a primer containing a single uracil at a defined 
distance from the end of the fragment [159]. The product is treated with a mix of 
UDG and endonuclease VIII creating a strand break at the site of uracil 
potentiating the dissociation of the 5´-oligonucleotide piece. The long single-




stranded 3′-extension can be subsequently used to assemble DNA fragments 
through complementary overlapping ends. Although linear DNA fragment 
populations comprising 1011 members have been created with USER technique 
for the needs of cell-free display systems [159], in cell-dependent systems the 
library sizes have so far been modest [160]. 
2.1.2.6 Construction of small diversity libraries 
While large omnipotent primary libraries are utilized to generate binding affinity 
against any target, small diversity libraries are applied to further improve an 
existing function, i.e. binding affinity [161], specificity [162] or stability [163]. 
Another characteristic difference is that as large repertoires require display 
techniques for selection, small repertoires are most often screened without a 
physical geno-phenotype linkage. Naturally in screening efforts, the library 
diversity must be tightly controlled to enable oversampling of the designed 
diversity [161]. The library size in a small scale experiment is adjusted according 
to the screening capacity from a thousand enzyme variants manageable with 
labour-intensive screening methods like GC/MS [162], to over a hundred 
thousand soluble Fab variants requiring high-throughput ELISA screening [161]. 
Naturally, the methods for large library creation are applicable to small scale 
experiments as well, but commercially available methods with minimal 
preparative procedures are generally preferred for small libraries. PCR assembly 
is often encountered as the construction method in small diversity experiments 
[161; 164], but the most common method is probably circular site-directed 
mutagenesis, which was commercialized by Stratagene as Quikchange kits [165] 
[74]. In Quikchange, two complementary oligonucleotides are synthesized with 
mutations in the middle of the primer. The oligonucleotides are hybridized to the 
target gene on a circular dam-methylated DNA. The desired end product is 
circular dsDNA of nascently synthesized strands carrying mutations on both 
strands at the mutagenesis site after PCR cycling. The remaining template and 
template-mutant chimers are eliminated by DpnI digestion, which cuts both 
homo- and heteromethylated DNA leaving the mutant product intact [166]. 
Subsequently, the product is transformed into bacteria for nick sealing and 
mutant analysis. This is a genuine and fast technique, but only very modest 
libraries from a few hundred to a few thousand members can be constructed by 
one reaction [162; 167]. 
Quikchange has some less cited commercial competitors using different 
mutagenesis techniques. For example, the GeneEditor site-directed mutagenesis 
system by Promega is based on the simultaneous annealing of mutagenic 
oligonucleotide with an oligonucleotide changing the substrate selectivity of an 
antibiotic resistance gene [168; 169]. The mutants are directly screened from 
plates containing the selection antibiotic mix, because a plasmid in which the 
resistance phenotype has emerged also contains, with high probability, the aimed 
mutations originating from the mutagenesis oligonucleotide, which was provided 




in molar excess to the selection oligonucleotide. There are several variants of the 
double oligonucleotide strategy based on reversion of a frameshift in a resistance 
gene [170], restoration of the origin of replication [171], and deletion of a 
restriction site [172]. 
Another Quikchange challenger is based on inverted PCR, such as the Phusion 
site-directed mutagenesis kit [173]. In this approach, a whole plasmid is copied 
by extending phosphorylated primers in opposite directions. One of the primers 
is carrying the mutations, and the mutagenesis is completed by blunt-end ligation 
and transformation [173; 174]. In our laboratory, a high efficiency version of the 
inverted PCR mutagenesis was applied by adding type IIS restriction sites in the 
primers. After PCR, the product is digested with the type IIS enzyme creating 
cohesive ends that are ligated to restore the template sequence with the mutations 
[article IV]. Inverted PCR coupled to type IIS digestion and ligation resulted in 
libraries of 105 to 107 transformants by electroporation into XL-1 cells. However, 
no reports exist of large billion member library creations with any of these 
methods. 
Site saturation mutagenesis is a special application of small libraries constructed 
by site-directed mutagenesis. In this technique, individual residue positions are 
randomized to allow all amino acids in the chosen position, while keeping the 
sequence otherwise invariant [161]. One subtype of this kind of approach is the 
alanine scanning, in which each position is, one by one, changed to alanine to 
probe the structural and functional aspects of molecular recognition [175]. In 
affinity reagent and enzyme development, site saturation mutagenesis is a widely 
applied method in fine-tuning affinity or substrate selectivity when changes in a 
limited set of residues at well-known positions are required [161; 176]. Even 
some exhaustive experiments have been described by the one-by-one 
randomization of each codon in a gene [164; 177]. 
2.1.3 Recombination 
2.1.3.1 Aims and applications 
Recombination is used to shuffle existing gene sequences to obtain additive 
beneficial mutations into single genes or to remove deleterious mutations. 
Molecular breeding, i.e. DNA shuffling, is a well-recognized tool for trimming 
existing protein functions but, strictly speaking, it does not produce de novo 
diversity per se, if that is understood as novel changes at the single base level. 
Genes can be shuffled either by homologous recombination requiring sequence 
similarity or by non-homologous recombination potentiating fusions of totally 
unrelated sequences. Site-specific recombination has been used to augment 
combinatorial diversity in primary antibody libraries by establishing novel pairs 
of variable domain genes in vivo. In some instances site-specific recombination is 




also a powerful technique for library cloning, an alternative to the conventional 
restriction digestion and ligation reactions. 
2.1.3.2 In vivo 
Some naïve antibody library builders have included additional genetic elements 
to increase the library size by in vivo recombination [140; 178]. Especially 
Cre/loxP-recombination has been explored to expand diversity by integrating 
loxP sites into DNA constructs followed by Cre recombinase induced 
recombination [179]. At least two large-scale studies exist of using Cre/loxP-
recombination to expand combinatorial diversity, in the first of which, VH-CH1 
heavy chain repertoire was transformed to E. coli and complemented via 
infection with a phage-packed VL-CL light chain repertoire accompanied with a 
dummy heavy chain [178]. Both the diversified heavy chains and the invariant 
dummy sequence were flanked with loxP sites enabling place switching by 
recombination. A bacteriophage P1 co-infection providing the Cre recombinase 
resulted in 6.5 x 1010 colonies resistant to all three markers originating from the 
plasmid carrying the heavy chain repertoire (ampicillin), phagemid carrying the 
light chain repertoire (tetracycline) and P1 bacteriophage (chloramphenicol). In 
theory, a perfect crossing of 108 unique heavy chains with 8 x105 unique light 
chains generates 8 x 1013 unique Fab fragments. In practice, the library size in 
this case was limited by the number of obtained colonies post P1 infection. The 
reversible nature of loxP recombination is a clear disadvantage of the method 
[180] as the phage progeny consists of both the perfectly recombined pairs of 
light and heavy chain and light chain members paired with the dummy 
companion. 
In another initiative, the Cre/loxP-recombination was revisited by infecting cells 
expressing Cre recombinase constantly with phage carrying loxP-VH-loxP-VL-
constructs [140]. A ratio of one cell per 200 phage resulted in the entry of several 
phagemids per cell, after which Cre recombinase catalysed the formation of all 
possible combinations of the present VH and VL domains. In this method, the 
primary phage progeny must be re-infected into fresh cells to restore geno-
phenotype linkage prior to selections. Modest libraries consisting of 7 x 107 
unique VL and VH domains were the foundation for the potential theoretical 
diversity of 5 x 1015 unique ScFvs. However, the authors assessed the final 
library size to be 3 x 1011, which was mainly limited by the number of cells 
cultured for re-infection in order to restore the geno-phenotype linkage [140]. 
Despite the claimed five times larger library size in the latter study, higher 
affinity antibodies were obtained from the previously described Fab-library of 
6.5 x 1010 members [178]. 
The mating of yeast S. cerevisiae can be utilized in an analogous manner to the 
Cre/loxP system in E. coli. In mating, two haploid populations with different 
mating types are let to form diploids, which are then selected for using 
compatible mating type-linked markers [181]. In this way, two immunoglobulin 




sublibraries of light and heavy chains have been brought together for display 
[181]. Homologous recombination in vivo is another common tool for library 
construction in yeast cells [146]. In fact, compared with transformation of 
circular DNA, larger repertoires were obtained by co-transformation of linear 
vector DNA with a library of genes provided as PCR products [182]. It is even 
possible to introduce site-directed mutations by transforming mere single-
stranded oligonucleotides [183]. This is, however, fairly inefficient compared to 
E. coli systems. Simultaneous mutagenesis of three regions of phosphoribosyl-
anthranilate isomerase gene in yeast with DNA oligonucleotides succeeded with 
0.01% efficiency, and for single sites, mutagenesis efficiency was 5% [184]. In 
vivo recombination and the recent proceedings in yeast transformation protocols 
have paved the way for yeast display libraries to become a vital competitor of 
phage display systems as the establishment of a yeast library comprising ten 
billion members has been reported [185]. 
2.1.3.3 In vitro 
The generation of new variants via homologous DNA recombination in vitro 
most typically relies on PCR assembly. The oldest technology in this niche is 
sexual PCR dating back to the year 1994 [186]. In sexual PCR, parental genes 
are fragmented with DNase I digestion and reassembled in a PCR reaction 
allowing new chimeras to be established. As the name implies, the end result of 
DNA shuffling superficially resembles the outcome of a crossing over at the 
meiosis of sexually reproducing organisms. In another method, termed StEP for 
“staggered extension process”, primers are extended for a very short period of 
time, denatured by heat and let to hybridize again, re-annealing to another 
template [187]. Typically, homologous genes shuffled by sexual PCR or StEP 
contained on average only 4 crossovers per gene per round of shuffling with a 
high share of intact parental sequences [188]. Therefore, another method termed 
RACHITT, based on more complete fragmentation of the parental sequences, 
was developed for higher efficiency shuffling [188]. 
RACHITT stands for “random chimeragenesis on transient templates” [188] and 
in this method, the source gene variants are first fragmented to single-stranded 
oligonucleotides. This is achieved by treating the source DNA with a lambda 
exonuclease destroying the anti-parallel DNA strand followed by a DNase I 
treatment cutting the remaining ssDNA into shorter pieces. Then, a transient 
template is prepared of the same source diversity as uridylated ssDNA, which 
corresponds to the destroyed anti-parallel strand, and the ssDNA fragments are 
let to hybridize. The non-hybrizing 5´-flaps are cleaved by the endogenous 
activity of Taq DNA polymerase, whereas the 3´-flaps are removed, and the final 
gap-filling performed, by Pfu DNA polymerase. The hybridized fragments are 
ligated by Taq DNA ligase, the template is inactivated by UDG and the chimeras 
are selectively amplified in a PCR with flanking primers. Although this method 
yielded on average 14 crossovers per gene [188], it is much more cumbersome to 
perform than the methods relying directly on PCR for assembly. A fully 




fragmentation-free method for recombination, known as synthetic shuffling, has 
also been devised [189]. If the sequence of the parental genes is known and they 
have adequate sequence identity, defined and degenerate oligonucleotides can be 
designed in silico to cover the genes. After synthesis, the oligonucleotides are 
assembled by PCR for selections [189]. 
The first technique for non-homologous recombination of distantly related genes 
was published in 1999 and termed ITCHY for “incremental truncation for the 
creation of hybrid enzymes” [190]. In ITCHY, the two genes to be joined are 
truncated at opposite ends with exonuclease III. The ends are polished with 
Klenow fragment and the library of fragments truncated at the 5´-end is ligated to 
the library of fragments digested at the 3´-end. Unfortunately, this process mainly 
creates out-of-frame-chimeras. Another issue is the time-controlled exonuclease 
treatment, which is hardly reproducible. Therefore, a variant of ITCHY, termed 
thio-ITCHY, was developed. In this method, the genes to be fused were 
synthesized in the presence of dNTPs doped with a low frequency of α-
phosphothioate analogs, which are resistant to exonuclease III digestion [191]. 
This innovation improves reproducibility as exonuclease digestion can be 
incubated into completion producing fragments with 3´-thiophosphate linkages. 
Surely, a combination of ITCHY and DNA shuffling is even more effective in 
creating chimeras and this combination is better known as SCRATCHY [192]. 
There are several strategies for recombination at defined sequence sites. Genes 
have been designed to contain IIS restriction sites that upon digestion and mixing 
induce directional crossovers at defined places [193]. In single framework 
libraries, the parental gene templates can be designed to contain unique 
restriction sites at appropriate crossover positions [article III], which can later be 
used to shuffle the retrieved specific clones and to segregate mutations. The same 
task could be performed without integrated designed features in the template 
sequence with primer sets containing type IIS restriction sites. Even nine 
fragments have been recombined by the latter method, termed “Golden gate 
shuffling”, including fragment PCR, digestion, mixing and ligation steps [194]. A 
summary of the recombination methods is given in Figure 7.  





Figure 7. Recombination methods for creating new combinatorial diversity of 
existing sequences. In homologous recombination the recombinants are 
constructed by the assembly of similar sequences. Synthetic shuffling is a 
homologous recombination method that uses fully synthetic oligonucleotides as 
the building blocks, whereas the other methods are carried out by shuffling 
fragments of parental sequences. The non-homologous recombination does not 
require any sequence similarity. ITCHY is based on a blunt-end ligation of two 
truncated parental sequences and golden gate shuffling takes advantage of type 
IIS restriction enzyme cut sites introduced by PCR. 
2.2 Methods for display and selection 
2.2.1 Geno-phenotype linkage and selection 
Genotype is the entire set of genes of an individual that together with the 
environment determines the observable properties of the individual, i.e. the 
phenotype. In directed evolution experiments a collection of genotypes are 
created, of which the individuals with the desired phenotype are selected for 
closer examination. Ranking the individuals according to the property of interest 
requires carefully planned experimentation. Typical qualities of proteins that are 
improved by directed evolution are stability [195], specificity [196], expression 
[129], and affinity [161]. 




For biotechnological exploitation, access to pure cultures of the desired variants 
is required and this is managed by spatial separation of the individuals. Most 
commonly this is achieved by picking colonies of bacteria or yeast cells from 
agar plates for culturing in separate vials, whereas sorting out a mammalian cell 
population to single monoclones requires dilutions to single-cell-per-well density. 
The hunt for the desired phenotype is commonly performed by screening small 
scale expression cultures of individual clones [161] or, in rare cases, by colony 
screening on plates, if the product of interest has a host protective phenotype or 
visually distinct appearance [article II; 197]. The capacity for direct screening of 
individual clones is limited and, therefore, the largest repertoires are sorted with 
display techniques. “Display” means a physical link between the expressed 
protein and the gene coding for it. The conceptual advantage the display 
techniques enable is the possibility to pool all member variants for selection. The 
majority of the diversity is lost in a single round of selection but still, the desired 
individuals qualifying for the selection are retained. After a display-dependent 
selection, the population contains a high share of individuals expressing the 
desired trait and, therefore, there is no need for massive screening campaigns in 
order to find the desired variant. The practical implications of display techniques 
are that selections are faster and larger repertoires are accessed than by direct 
screening efforts. A summary of the different display methods is given in Figure 
8. 
The selections of phage displayed libraries may be conducted on a collection of 
1013 particles in a single 1.5 ml eppendorf tube [119], whereas in cell-free display 
systems libraries consisting of even 1015 members have been managed [198]. In 
yeast display, 107 cells may be routinely sampled with fluorescence-activated cell 
sorting (FACS) in one run and a pre-selection with magnet activated cell sorting 
prior to FACS facilitates the mining of even 100-fold larger primary repertoires 
[199]. The results obtained from a library initiative are dependent on the quality 
of the displayed library and the mastery of setting effective selection conditions 
for purposeful enrichment. Selections may, for example, rely on washing the 
unbound geno-phenotype units from a solid surface coated with the protein of 
interest or on monitoring the binding of labelled target proteins on the library 
members in a flow cell. The review of selection conditions is a subject of its own 
and exceeds the limits of this work. Selection techniques are, however, 
mentioned if they are an integral part of the display system. 
2.2.2 High-throughput screening 
Probing between a hundred and a thousand clones manually is easily managed as 
96-well microtiter plate expressions, but sampling libraries of several thousand 
members, or more, requires high level of automation. There are some approaches 
to alleviate the labor intense nature of screening efforts, which will be briefly 
summarized here. A colony filter assay has been described in which a large 
antibody library was expressed directly from cells as a mat of colonies growing 
on a master filter [200]. The antibodies secreted by the colonies were in contact 




with another antigen-coated filter. The antigen-bound antibodies on the second 
filter were detected and the hit regions at the corresponding site on the master 
filter collected for another round of colony separation and screening. Specific 
monoclonal antibodies were obtained after two rounds of filter screening [200]. 
Another group reported the simultaneous screening of 18 342 clones with 
antibody arrays [201]. In this technique, samples of expression cultures were 
spotted at high density on antigen-coated filters, washed and the bound 
antibodies revealed with a protein-L-horseradish peroxidase conjugate. 
Nonetheless, the latter technique first required the growth of the individual 
clones on microtiter well plates before gridding [201]. The antibody arrays have 
been miniaturized further from the membrane scale to microarrays spotted on 
microscopic slides [202]. 
If the screening capacity cannot be augmented to encompass all interesting 
variants at once, screening may be started with limited diversity libraries 
followed by the genetic recombination of the found beneficial mutations and 
sampling of their characteristics. An elegant and massive experiment of this type 
was carried out by the medical company Bayer in search of a higher affinity 
variant of adalimumab, the leading antibody drug on the market to treat 
rheumatoid arthritis [161]. The quest was started by screening site-saturation 
libraries with diversity set at chosen CDR-loop positions. The libraries consisted 
of single-site mutants originating from NNK-randomization and double-site 
mutants originating from NNK-NNK-randomization at consecutive positions. 
From this screen the positions that made major contributions to the affinity 
improvement were identified and taken as anchor points. First, all combinations 
of the mutations at the anchor points, 3840 genotypes in total, were generated 
and analysed, after which 12 new, less significant, mutations found in the 
primary screening were sampled using single anchor-point-optimized scaffold as 
the template. For this purpose, a library was constructed in which each of the 
new positions was allowed to variate between the affinity-improving and the 
wild-type residue. The best clone from this screen contained ten changes to the 
original adalimumab. On top of this, the affinity maturation of adalimumab was 
finalized by randomizing two further residues. In the three-step screening effort 
the original adalimumab affinity was first improved tenfold to 10 pM by the 
anchor point co-optimization, followed by a tenfold improvement to 1 pM by the 
additional optimization of the second sphere mutations. Eventually, from the final 
screen of clones originating from the library of two novel randomized positions, 
a clone with 400 – 500 fM binding affinity was found [161]. 
2.2.3 Phage display 
Phage display is the most widely applied display technology due to its 
robustness, low price and well-established track record [203; 204]. Several coat 
proteins of filamentous phage can be used for the display of the protein of 
interest as direct genetic fusions. The most commonly employed coat proteins for 
display are p3, p9, and p8, of which p3 and p9 are able to display peptides and 




proteins alike [137; 205], whereas p8 is mainly good for peptide display [206]. In 
addition, p7 and p6 display has been experimented [205; 207], but they remain 
without widespread applications. There are also numerous genetically engineered 
variations of display, especially with p3. The fusion of the protein of interest to a 
truncated p3 lacking the N-terminal infection domains leads to higher display 
efficiency compared to the full-length p3 display [208] and, in Cysdisplay, p3 is 
linked to the protein of interest via a disulfide bridge [156]. Selectively infective 
phage display systems have also been developed in which a non-infective phage 
displaying a protein of interest regains infectivity through interaction with a 
binding partner fused to the infectivity-restoring full-length p3 protein or merely 
to the infection domains [209; 210]. Work has been carried out to facilitate multi-
copy display of proteins along the phage rod via p8 by genetically engineering p8 
itself [211] or by optimizing the linker properties between p8 and the protein of 
interest [212]. 
The numerous display modes developed for the filamentous phage can be 
classified to display systems operating on phage or phagemid vectors. In phage 
vector display, the DNA sequence to be displayed is added to the wild-type phage 
genome. In 1985, in the first report on phage display of this type, peptide-coding 
sequences were fused to be part of the p3 gene [213]. In this mode, every p3 
displays the peptide on the coat. As the fusion peptides may interfere with phage 
assembly, an extra copy of p3-peptide fusion gene was inserted into the phage 
genome in the next generation of display vectors allowing also wild-type p3 to be 
simultaneously expressed [214]. An alternative to the latter is the phagemid 
system in which the coat fusion is provided from an independently replicating 
plasmid containing also genetic elements for phage packing [215]. Currently, 
most large phage libraries are built on phagemids due to the ease of 
manipulation, higher transformation efficiencies and improved genetic stability. 
Phagemid systems require an additional infection with a wild-type phage to 
provide all the other proteins needed to make single-stranded DNA and new 
virion particles [215]. These phages, termed helper phages, have a modified 
packing signal to favour the packing of the phagemid instead of the virus genome 
into the virions being assembled [216]. There are also a variety of helper phage 
modifications to allow, for example, multivalent display [217] and to inhibit 
wild-type phage infection with trypsin-cleavable p3 [218]. 
Several types of protein libraries have been displayed on filamentous phage, of 
which, antibodies have received most publicity as the pioneers in the field with 
multiple examples of developed valuable products [219]. The proteins displayed 
on the N-terminus of p3 must be secreted into the host periplasm for proper 
display, which is well compatible with antibody fragments that preferably fold in 
the oxidative environment of the periplasmic space [220; 221]. Libraries of other 
proteins have also been displayed on filamentous phage including lipocalins 
[222], fibronectin type III domains [223], Z-domains of protein A [224], and 
ubiquitins [225], to mention a few. Display may be dramatically improved by 
changing the signal sequence from post-translational, which is the most widely 
applied, to co-translational or twin-arginine translocation [221; 226].  




Filamentous phage is not very well suited for the display of proteins folding in 
the cytoplasm and therefore, the successful display of a library may be achieved 
only by turning to the second popular phage display system, which is the T7 
bacteriophage [227]. T7 bacteriophage is a lytic phage, and consequently, display 
does not require translocation [228; 229]. A more balanced peptide library 
presentation was also obtained by T7 phage than by filamentous phage indicating 
translocation-related problems [230]. In relation to the capsid anchor protein, T7 
phage supports C-terminal display, whereas N-terminal display is far more used 
with filamentous phages [213; 231]. The drawback of T7 display is the large 
genome size of the virion, difficulties in packing the modified DNA for infection 
and the 10 - 100-fold lower titers compared to filamentous phage samples [231]. 
Also some other phages have been tested in display, including λ-phage [232], T4 
phage [233], baculovirus [234], and adenovirus [235], but they have not yet 
found a wider audience or are still at a developmental stage. Especially gene 
therapy by viral delivery is under intensive research and many intriguing 
undertakings are on-going to improve viral targeting and to evade the immune 
system with the aid of displayed polypeptides [235; 236; 237]. 
2.2.4 Cell surface display 
Only one year and four months after the emergence of the concept of phage 
display a foreign antigen was displayed on the outer membrane of E. coli as a 
fusion to the trimeric integral outer membrane protein LamB retaining its 
antigenic properties as confirmed with antigen-specific immunoprecipitation and 
immunoelectron microscopy [238]. Since then, peptides [239], enzymes [240], 
and antibody fragments [241] have been displayed on the surface of E. coli for 
directed evolution experiments. As E. coli is a well-studied organism, several 
pathways have been established for cell surface display. 
In the first application using flow cytometry to sort cell-displayed libraries, a C-
terminal antibody library was fused to the outer membrane protein OmpA of E. 
coli and sorted according to the ability to bind fluorescently labelled antigen 
[241]. FACS is still the most common method for cell display selections. In a 
variant of the OmpA-display, a library is inserted into a loop of OmpA for 
constrained peptide display [242]. Other proteins used for membrane anchoring 
are the inactivated form of esterase EstA from Pseudomonas aeruginosa and the 
ice nucleation protein from Pseudomonas syringe, both enabling N-terminal 
display [243; 244]. The outer membrane protein OmpX was engineered by 
circular permutation to enable simultaneous N- and C-terminal display [245], 
which was applied to peptide affinity maturation by displaying the library in the 
N-terminus and a tag in the C-terminus for expression normalization in FACS 
[246]. 
Anchoring points other than the outer membrane for E. coli-hosted surface 
display are the flagellum and inner membrane. In one endeavor, which is now 
commercially available [247], a peptide library was inserted into the active site 




loop of the thioredoxin gene, which was then inserted into the flagellin gene 
enabling display on the flagellum [239]. It was shown by anchored periplasmic 
expression that at least antibody fragments could be tethered to the inner 
membrane either by a small N-terminal leader peptide of NlpA or as N-terminal 
fusions to the filamentous phage p3 [248]. The permeabilization of the outer 
membrane is required for the fluorescently labelled antigens to access the inner 
membrane for subsequent sorting. In addition to antibody fragments, inner 
membrane display has been exploited in engineering G-protein coupled receptors 
for increased expression [249]. 
Gram positive bacteria can also be used to present large combinatorial diversities 
as demonstrated with Staphylococcus carnosus, which was harnessed to display 
affibodies and nanobodies [250; 251]. Yet another platform is to display proteins 
on the spores of Bacillus subtilis, a well-established system for display of defined 
sequences, although library applications have only recently been reported [252]. 
Yeast display has been actively exploited ever since the first report dating back to 
1997 [253]. Proteins of eukaryotic origin are displayed in a more natural context 
on yeast than on bacterial host cells. Both post-translational modifications and 
the ability to express complex proteins, such as full-length antibodies, are central 
advantages of yeast display [254]. In addition, bacterial surface display is 
speculated to be sterically hindered by the lipopolysaccharide layer [253]. The 
most frequently used display technique with Saccharomyces cerevisiae is the 
fusion of protein library to α-agglutinin [255]. The agglutinins are involved in the 
adhesion of yeast cells during mating [256] and, therefore, the protein-protein 
interaction surface, tested by nature, is an attractive target for library display. α-
agglutinin consists of two subunits of which Aga1p is covalently tethered to the 
yeast cell wall, and Aga2p is linked to Aga1p via two disulfide bridges [256]. 
Proteins are displayed as C-terminal fusions to the Aga2p, which is also the 
natural site for adhesion interaction [253; 257]. Various protein libraries have 
been displayed via agglutinins on the yeast surface, including antibody fragments 
[258], single chain TCRs [259; 260], fibronectin III domains [146], 
transpeptidases [261], and fluorescent proteins [262]. In addition to directed 
evolution, the agglutinin-site has been widely utilized as a general attachment 
point in whole-cell biocatalysis for the linking of enzymes operating in the 
extracellular environment [255]. 
At least eight other yeast proteins with varying expression levels are suitable 
anchors for surface display [263]. There are also adapter-mediated surface 
display systems for yeast, including the protein A and Fc pair, the cohesin and 
dockerin pair from Clostridium cellulovorans [264] and the coiled-coil pair of 
GR1 and GR2 [265]. In another adapter display system surface-expressed avidins 
were used to capture library members fused to in vivo-biotinylation domains 
[254]. Avidin capture was reported to allow the display of even full-length 
antibodies [254]. Besides S. cerevisiae, cell display systems have been 
established for some other yeast species such as Pichia pastoris and Yarrowia 
lipolytica [266; 267], but without notable library studies so far. There are also 




innovative examples of using yeast display for challenging selections, such as 
changing protease selectivity [268] or engineering bond-forming enzymes, both 
requiring custom made multicomponent selection platforms [261]. 
In addition to bacterial and yeast display, there are reports on mammalian surface 
display especially for antibody engineering [269; 270]. In one initiative, full-
length IgG antibodies were displayed on HEK239 cells and in another, on CHO 
cells, as a fusion to a C-terminal transmembrane domain [269; 270; 271]. 
Preliminary studies on insect cell display have been conducted with Sf9 for the 
display of major histocompatibility complex class II proteins [272] but, to date, 
the largest libraries on insect cells have been in the range of 105 members [273]. 
 
 
Figure 8. Overview of cell-dependent and cell-free display methods. POI: 
protein of interest. Arrows indicate different localities used for display. 
2.2.5 Ribosome display and related instant links 
The reconstitution of translation and transcription in vitro without living cells in 
1961 [274] was a prerequisite for the development of cell-free display systems. 
The cell-free transcription and translation extract is obtained by gently lysing E. 
coli cells and separating the soluble fraction by centrifugation [275]. 
Components, such as amino acids, template DNA and energy source, are supplied 
in the obtained S30 extract to start translation. Cell-free translation technology 




has been further refined by reconstituting translation from purified components 
minimizing uncontrolled side reactions [276]. In ribosome display, a ribosome 
remains non-covalently attached at the 3´-end of the translated mRNA while still 
linked to the nascently synthesized polypeptide due to the absence of stop codons 
in mRNA [133]. The rescue of the target mRNA is simply performed by reverse 
transcription and PCR post selection. In a proof-of-concept study in 1994, a 
target peptide was enriched from a library of 1012 members with a monoclonal 
antibody [133] and the display of full-length proteins was demonstrated three 
years later [277]. The stability of the system has been enhanced by using low 
reaction temperature and high concentration of magnesium ions [277]. Measures 
to silence native mRNA quality control system may also play a role in retaining 
ribosome-mRNA-complexes intact [277]. 
Despite the protective measures, ribosome display is fairly labile without 
covalent linking. Therefore, a technique called mRNA display was developed, in 
which the mRNA was covalently linked to the translated protein by adding a 
puromycin-DNA adapter to mRNA prior to translation [278]. The ribosome stalls 
at the peptidyl acceptor antibiotic puromycin located at the 3´-end, after which 
the mRNA is reverse transcribed to form a stable mRNA-cDNA hybrid and used 
for selections. Target genes are rescued via the cDNA by PCR [278]. A variant of 
this technique is cDNA display (Figure 8), which also relies on the puromycin 
linking and reverse transcription with the exception that the puromycin 
attachment site is in the centre of a DNA adapter allowing the use of the free 3´-
end of the adapter hairpin to prime cDNA synthesis linking the polypeptide 
covalently to the synthesized puromycin-tagged cDNA, and not to mRNA as in 
the first version [279]. Instant linking of the formed protein to the coding gene 
has also been accomplished with a RepA fusion protein [280]. In this method, 
termed CIS display, a DNA sequence of the origin of replication is added to the 
gene library DNA and as the RepA-protein fusion is translated, RepA binds to the 
dsDNA ori-element. Only a single library-scale peptide experiment has been 
reported using CIS display [281]. 
One major advantage of the cell-free systems is the possibility to reprogram the 
genetic code to insert unnatural amino acids into a polypeptide via modified 
tRNAs. Recent developments in charging tRNAs with ribozymes has widened 
the spectrum of incorporable unnatural amino acids [282]. For example, large 
libraries of in vitro-translated peptides have been recently connected to form 
constrained circles with the help of incorporated unnatural amino acid residues 
followed by selection with mRNA display [283]. The open operating system also 
allows the addition of other heterologous components, such as chaperones, to aid 
in protein folding [284]. 
Another benefit of the open operating system is that the library size is not limited 
by transformation efficiency as genes are added directly as linear DNA to the 
transcription and translation mixture. Furthermore, in all selections requiring 
reverse transcription, the high error rate may bring beneficial mutations during 
library rescue [285]. In general, mRNA display is a well-established technique 




that has been widely applied to engineer fibronectin domains and ankyrin repeat 
proteins, some of which have already entered clinical trials for medical use [286; 
287; 288]. Aside from developing novel pharmaceuticals, ribosome display has 
also found use as a platform to improve the stability and expression of 
established protein drugs [289]. 
2.2.6 In vitro compartmentalization 
Double-stranded DNA is more stable than single-stranded DNA and far more 
stable than mRNA. Consequently, dsDNA would be the preferred genotype 
partner for establishing geno-phenotype units. Because DNA is not physically in 
contact with the encoded protein, the problem is that how to cross-link the gene 
present as dsDNA with the corresponding nascently synthesized polypeptide. 
Several solutions have been tested to answer this question by isolating the gene 
and the encoded protein to the same compartment for linking, before the 
disruption of the isolation and selection with the freshly coupled geno-
phenotypes. 
One of the most common formulations for in vitro compartmentalization (IVC) is 
the use of water-in-oil emulsions, which typically yield droplets of 2 µm in 
diameter with 5 fl volumes [290]. A 50 µl reaction may consist of 1010 artificial 
cells. Optimally, each contains a single DNA template that can be amplified, 
transcribed and translated for geno-phenotype coupling [291]. DNA may be 
linked to the encoded protein non-covalently as in STABLE-display in which 
biotinylated DNA binds to the in-droplet expressed streptavidin-protein fusion 
[292], or via a zinc finger domain fusion binding the recognition element 
attached to the template DNA [293]. The covalent linking of the translated 
protein to the corresponding template DNA has been achieved, for example, by 
fusing the protein of interest with DNA methyltransferase M. HaeIII (Figure 8). 
M.HaeIII covalently binds to a 5-fluorodeoxycytidine (F) in a methylation target 
sequence 5´-GGFC-3´ placed at the end of the encoding DNA molecule, 
establishing a stable link [294]. 
Geno-phenotype linking may also be arranged via microbeads. In one example a 
monoclonal antibody attached to streptavidin coated microbeads was used to 
capture an in-droplet synthesized enzyme [295]. As the template DNA and 
enzyme substrate were biotinylated, the beads displaying the active enzyme and 
desired product could be sorted with FACS using labelled anti-product and anti-
enzyme antibodies. A streptag variant of the microbead display has also been 
described [296]. 
Thermophilic DNA polymerase variants have been successfully evolved by self-
replication in intact emulsion droplets [297], which is a fairly straight-forward 
application for IVC-techniques. However, the most interesting applications of 
intact droplets are in the field of enzyme engineering, for example, by following 
fluorescent product accumulation into droplets with FACS. To be amenable to 




sorting, the encapsulation of the components in either water-in-oil-in-water 
double emulsions [298] or liposomes [299] is required. Liposomes have the extra 
benefit of allowing membrane protein display as they consist of a phospholipid 
bilayer [299]. Cell-free methods have also been applied to the selection of 
heterodimeric proteins by allowing gene linking in IVC-droplets followed by 
mRNA display [300]. 
2.3 Aspects of functional display 
2.3.1 Evolution 
During the course of a directed evolution experiment the frequency of alleles in a 
population are changed. Firstly, the diversity of the allele pool is reduced 
typically to a few hundred variants and, secondly, the frequency of alleles with 
experimentally favoured traits is tremendously increased. However, one of the 
lessons to be learnt from the modern synthesis of evolution theory, emphasizing 
the reproductive success instead of mere survival [301], is that selection 
experiments may be substantially skewed by secondary parameters that 
contribute to the overall fitness of the clones. 
Especially in situations in which the fitness of an allele changes over time, the 
dominating allele at the end is the one with the highest geometric mean fitness 
[302]. This finding is common in phage display as deleted forms of library 
members are often encountered after selection on a target antigen [303; 304]. 
Although the clones that bind to the provided antigen with the required affinity or 
avidity are enriched in the selection phase, the clones that propagate the best take 
over the population in the following infection and growth phase. The displayed 
heterologous proteins often have toxic effects on the E. coli host promoting the 
expansion of the aberrant clones [article III]. 
Particularly, if the selection pressure is not persuasive enough, or when it is not 
yet in operation, the alleles are enriched according to the secondary traits. This 
phenomenon has been strikingly shown with landscape phage displaying peptides 
as p8 fusions on the filamentous phage capsid [305]. Extensive biases were 
observed already in the primary phage population prior to selection [305]. 
Ultimately, peptides that interfere with the phage assembly are entirely excluded 
from selections, although they would otherwise have excellent binding 
properties. 
2.3.2 Fitness landscape 
Proteins do not possess equal evolvability. The natural history of proteins has 
shown that diverse functions have arisen from some folds, but not from others 




[306]. For example antibodies are tunable to recognize a wide variety of 
structures via mutations and genetic recombination [307] and, therefore, the 
immunoglobulin scaffold is considered highly evolvable. However, the acquired 
surface architecture of the protein sets limits to the obtainable fitness increments 
that additional genetic fine-tuning can offer. Although a local optimum for 
maximum affinity would be reached by single substitutions, the absolute 
optimum may remain unachievable, as it would require a fundamentally different 
surface architecture. This idea is coined in the concepts of rugged and smooth 
fitness landscape [308; 309]. Directed evolution in a rugged landscape leads to 
several local adaptive peaks, whereas in a smooth landscape the protein is 
evolvable to the global absolute maximum fitness via several routes [309]. 
Protein stability has dual effect on the fitness landscape. On one hand, stability 
promotes protein evolvability as a stable scaffold tolerates more mutations than 
an unstable one, which has been demonstrated with cytochrome P450 
peroxygenase variants [310]. A library built on a more stable enzyme produced 
three times as many different solutions for hydrolyzing novel substrates than a 
library based on an unstable enzyme [310]. On the other hand, the acquisition of 
novel functions requires structural plasticity, which may be hampered by 
excessive stability [311; 312]. A recently proposed hypothesis for predicting 
broad evolvability joins these two ideas together as it states that folds with a 
physically separated stable core and active site provide high conformational 
plasticity and stability in the same package implying a smooth fitness landscape 
[313]. As only a tiny portion of the total available sequence space can be scanned 
with any combinatorial library initiative, the scan inevitably resembles a sparse 
shotgun firing pattern. Keeping this in mind, the prediction is that in a rugged 
fitness landscape of rigid proteins, further variant development would lead to a 
local, compromised fitness trait, whereas in a smooth landscape of polar 
(separate core and active site) structures, further development would gradually 
lead to the ultimate fitness peak. 
2.3.3 Library size 
The high transformation efficiency of E. coli enables the construction of libraries 
of 1011 members, which are displayed on phage or on bacterial surface [314]. 
Starting from ready-to-transform library DNA, 109 - 1010 transformants are 
routinely obtained in our laboratory in one working day [article I; 119]. Yeast 
transformation is less efficient than bacterial transformation and, therefore, 
typical yeast display libraries consist of 106 -107 members although, in rare cases, 
109- to 1010-membered libraries have been reported [185; 315]. Libraries 
accessible by in vitro compartmentalization are larger or close to the E. coli 
library sizes as the physical dimensions of the compartments resemble the size of 
bacterial cells [290]. Template dilution to a concentration at which only single 
template exists in the artificial cell is a prerequisite for IVC-based display 
techniques setting also limits for the maximum number of members. The instant 
linking of geno-phenotypes by ribosome display and related techniques provide 




significantly larger library sizes up to 1013 - 1014 members and are ultimately 
limited only by the number of ribosomes [316]. There is also a difference in the 
way library DNA is brought to life, as already discussed above. In its most 
simple form, mere linear DNA with a promoter and the gene to be translated is 
needed for ribosome display, whereas the DNA to be transformed into E. coli 
must be provided as circular DNA with required replication and selection 
features. 
2.3.4 Randomizing for maximum functionality 
Even the highest achievable library size of 1014 members is a tiny sample of the 
full sequence space of a small polypeptide of 100 residues, i.e. 20100 variants. 
From another point of view, screening capacity is most often the main limiting 
factor especially in enzyme development projects, for which display methods 
cannot be established. When the physical dimensions of the screening capacity 
have been fully explored, the only way forward is to improve upon quality, which 
in directed evolution experiments translates into maximizing the number of 
functional clones in the population. 
Firstly, to be functional the clone must be in an open reading frame. A generally 
known source of base deletions and insertions are the commercial synthetic 
oligonucleotides, which may have error rates of 1% per base in microscale 
synthesis [317]. Libraries requiring the incorporation of multiple 
oligonucleotides at various positions for diversity generation are especially 
vulnerable to oligo-derived mutations as a frameshift at any of the randomized 
sites will destroy the display. There are a few ways to tackle this problem. The 
mutated genes may be preselected for functionality, for example, as β-lactamase 
fusions before the final randomization [156]. The quality of the oligonucleotides 
may also be augmented by choosing the oligonucleotide provider with care or by 
consensus-based error correction, if oligonucleotides with defined sequences 
have been used for diversification [318]. 
Secondly, the integrity of the secondary sequence elements plays a major role in 
conserving functionality [319; 320]. A β-strand has been claimed to tolerate less 
mutations than an α-helix [320], and the surface exposed loops allow more 
diversity than the hydrophobic core [321]. Another general rule states that 
hydrophobic residues may be exchanged for other hydrophobic residues, as well 
as hydrophilic residues for other hydrophilic residues, but not for those of the 
opposite chemical character [321]. The rational design of mutational diversity by 
the above-mentioned principles aims to retain as many variants as possible in a 
correctly folded state increasing the overall quality of the library. However, if the 
aim is to change specificity or evolve affinity, the sites of mutagenesis providing 
the desired diversity with the highest probability are the residues or regions 
involved directly in catalysis or in the binding interaction. The implementation of 
the latter strategy requires more elaborate structural information, whereas a less 
accurate structural prediction is adequate for the general restriction of 




mutagenesis, which is achievable directly from primary sequence with homology 
modeling [322]. 
There are several conceptual strategies and computer programmes for guiding the 
design of focused diversity libraries [323], of which the combinatorial active-site 
saturation test, i.e. CASTing, is one of the most frequently applied [324]. The 
idea of CASTing is to simultaneously create site saturation mutagenesis libraries 
of two residues at the active site of an enzyme. All the combinations of the two 
varying residues still form a repertoire screenable by any method and are the 
population with the maximum likelihood of finding altered variants. The library 
quality is further increased by focusing on the mutational content in the selected 
positions. Which substitutions are allowed in each position to serve the purpose, 
and how to capture the diversity in synthetic DNA oligonucleotides in the most 
non-redundant way? A software programme has also been developed to assist in 
this dilemma, and to assess the number of clones to be screened for the full 
coverage of the designed diversity [325]. Especially in antibody library designs, 
diversity focusing for maximum functionality is fairly straightforward due to the 
available databases of known antibody sequences [134; 143]. The knowledge of 
the structure-function relationships of antibody-antigen interaction has inspired 
library initiatives that, instead of mirroring the full native repertoire, try to evolve 
affinity reagents for specific subgroups, such as haptens or peptides, by limiting 
the diversification to carefully selected positions and content to tune the binding 
profile of the library [326; 327]. 
2.3.5 Folding, translocation and leader peptides 
All proteins are not amenable to filamentous phage display [221; 227]. The 
history of phage display is linked to peptide and antibody display, which was a 
fortuitous coincidence leading to successful development projects. Peptides are 
fairly unstructured if not constrained and, therefore, suitable for display with any 
platform. Proteins, however, require specific conditions for folding [328] and, 
consequently, the display of a library of proteins in a new host, disconnected 
from its natural environment, may not work. To be displayed on the p3 or p8 of a 
filamentous phage particle, the protein must be secreted into the periplasmic 
space [221]. Traditionally in filamentous phage display, this is achieved by 
directing the fusion protein to a post-translational secretion (SEC) pathway with 
a signal peptide [208]. Antibody fragments are guided to the inner membrane and 
translocated in an unfolded state by the post-translational signal sequence to the 
periplasmic space, where folding subsequently takes place as it requires disulfide 
bond formation [329]. Although the display of antibody fragments is well 
compatible with the SEC-pathway, the display of cytoplasmic proteins may be 
severely impaired through SEC, which has been attributed to rapid folding 
kinetics [330]. 
Fortunately, there are two alternative pathways for protein secretion in E. coli. 
Co-translational translocation allows the display of more stable scaffolds by 




synthesizing the polypeptides of interest directly through the membrane to the 
periplasmic space [221]. This was dramatically shown with a fibronectin type III 
domain, which is based on a stable β-sandwich fold without a disulfide bond, by 
a 1000-fold increase in display when changing from post- to co-translational 
pathway [331]. The third translocation pathway called twin-arginine translocation 
(TAT) secretes folded proteins across the plasma membrane enabling the display 
of cytoplasmic proteins on the filamentous phage [332]. TAT-pathway has been 
shown to be compatible with truncated p3 and p9 display, whereas display with 
full-length p3 was impaired [226; 330]. Utmost caution should be taken in 
generalizing these findings as they most likely are fold-dependent, and the 
experimental verification of proper display is of central importance prior to any 
library work. 
Naturally, cytoplasmic proteins can be directly displayed on the lytic T7 phage as 
display does not require export to the periplasm [229]. The cytoplasmic proteins 
are also compatible with ribosome display techniques, which is the standard 
platform for working with, e.g., stable ankyrin repeat proteins [288]. Small 
proteins, such as ScFvs, are amenable to several platforms, whereas the display 
of large proteins, such as full-length antibodies, is still limited to yeast and 
mammalian hosts [254; 269]. All in all, when committing to novel library 
projects, it is clear that understanding the chemical, biological and theoretical 
limitations of the particular system are necessary for successful implementation. 
A checklist for new library initiatives is provided in Figure 9. 
 
Figure 9. Checklist for new library initiatives. 




2.3.6 Evolving enzymes 
The establishment of geno-phenotype linkage is the major challenge in 
engineering proteins capable of catalysis by directed evolution as the substrate 
and product are dissolved in the surrounding solution. The traditional enzyme 
engineering relied on a high-throughput screening in well format [333] or on 
colony screening approaches, if the emerging trait was selectable, e.g., an 
enzyme conferring a novel antibiotic resistance [article II]. Since then, 
fluorescence-activated flow cytometry has become a major tool in enzyme 
engineering as it potentiates the screening of libraries that are several orders of 
magnitude larger than those manageable with single well assays. However, 
FACS-selections require individual study designs as there is no generic format 
suitable for all enzyme selections, in contrast with affinity generation, in which 
solid phase separation is always an option. 
For some FACS-selections, the substrate may be directly turned visible by 
fluorescence tagging. For example, in selecting sialyltransferases for better 
catalytic efficiency, the successful transfer of a sialic acid to a fluorescently 
tagged lactose derivative inhibited the transport of the fluorescent product out of 
the cells and, as a result of this, the improved catalysis was eminent as a higher 
cell fluorescence [334]. The activity of generated Cre recombinase variants for 
recombining at a novel sequence site has also been monitored by FACS [335]. In 
this study, the exchange of a reporter gene GFPuv for EYFP by recombination 
resulted in altered fluorescence, which was discernible in FACS. 
There are several novel in vivo screening platforms linking an enzymatic reaction 
with reporter enzyme expression. In one study, cephalosporinases were 
developed with a yeast-three-hybrid assay, in which the basal transcription of 
LacZ gene was disrupted by the cleavage of a β-lactam substrate linking the 
DNA-binding protein LexA and transcription activation domain B42 [336]. In 
another approach, the fusion molecule of a ligand-responsive RNA aptamer and a 
poly-A tail-cleaving ribozyme was used to modulate the expression of GFP 
[337]. In the ribozyme-aptamer fusion, either the ligand binding or the cleaving 
domain was properly folded. In the native state, the ribozyme was actively 
cleaving the poly-A tails of the GFP transcripts sustaining the low expression 
level of the reporter, whereas upon ligand binding the ribozyme was misfolded 
leading to more stable transcripts and higher GFP expression [337]. 
There are also variations of the cell surface display enabling the selection for 
catalysis. A general approach for protease trimming was claimed by a system in 
which the cleavage of an intracellular peptide substrate leads to the display of the 
cleaved part on the cell surface, which can subsequently be detected with a 
specific labelled affinity reagent in FACS [268]. Serine proteases have been 
engineered with a different strategy, in which a substrate was attached to the 
surface via electrostatic interactions. A functional surface-displayed protease 
cleaved the substrate, releasing a quencher arm, after which, the fluorescence of 
the surface-tethered part was restored [240]. 




Particularly in the early days, phage display was used for enzyme development 
by using stabilized transition analogs to capture the enzyme-displaying phage for 
washing [338], or by trapping the products catalyzed by the displayed enzyme to 
the phage coat, for example, with maleimide activated linkers, followed by a 
product-specific affinity selection [339]. However, the recent onrush of IVC-
methods has dominated the enzyme evolution landscape and will continue to do 
so in the future. The main benefits of IVC are that the substrate and product are 
linked to the gene product as all are confined to the same droplet. Especially the 
FACS-compatible double emulsions have already been applied to the engineering 
of a β-galactosidase [340] and a paraoxonase [341]. There are also novel ways of 
droplet manufacture with microfluidics further miniaturizing the screening effort 
to picoliter scale [342]. With the newest droplet-FACS platforms, 107 droplets 
may be screened in 3 hours, which is a major improvement to the classical 
robotic screening in microtiter plates, which can reach 105 assays per day at best 
[342]. 
2.4 The future of experimental directed evolution 
The proceedings in de novo gene synthesis have made genes available for 
everybody at diminishing prices. It is trivial to order genes directly as codon-
optimized for expression in the final host, although the guidelines regarding the 
maximum expression of heterologous proteins are still under debate [343]. The 
progress in massive parallel oligonucleotide synthesis creates new opportunities 
for the construction of libraries with well-defined diversity and sets new 
standards for error correction and quality control [344]. Furthermore, the TRIM 
technology is becoming an ordinary method for library construction as it has 
recently become commercially available leading to the better control of 
randomized diversities. In the future, the synthetic genes may even be based on 
de novo protein designs that to date do not exist. One triumph in this field was 
the computational design of an enzyme that catalyzes the Kemp elimination 
reaction, for which no natural enzyme has been found [345]. However, in this 
work extensive directed evolution was also required to further increase the 
catalytic activity. De novo protein design is at an early stage, but major 
breakthroughs will be seen with the improving computational design algorithms. 
The results obtained from directed evolution experiments also provide vital 
information to support the software development. 
Second generation sequencing (SGS) techniques have been eagerly implemented 
in directed evolution research from early on and their significance continues to 
increase. SGS has a dual role in supporting directed evolution studies. On one 
hand, massively parallel sequencing is a potentiating tool for analyzing the 
quality of created libraries in detail [143], for choosing hits from complex 
experimental set-ups [346] and for gaining knowledge of the properties of 
proteins via the inspection of mutagenesis profiles [143; 346; 347]. On the other 
hand, the metagenomics of uncultivable microbes, which is dependent on the 
massively parallel sequencing for species identification and genome mining, is a 




source of thousands of novel enzymes [348], which can be further manipulated 
by directed evolution, both for the efficient expression in a heterologous host and 
for the catalysis of unforeseen reactions. 
Synthetic biology has progressed from introducing single genes to introducing 
whole metabolic pathways into the desired host organisms for the production of 
natural and unnatural products. Metabolic engineering is especially inspired by 
the visions of biofuel production in micro-organisms and, in this context, directed 
evolution is a practical tool to adjust the multi-component systems for maximum 
production [349]. Heterologous pathways have been fine-tuned with promoter 
libraries [350], transcription factor libraries [351] and the libraries of tunable 
intergenic regions [352]. Pathway trimming has also been experimented with 
gene shuffling by integrons [353]. 
The arsenal of new methods for genome-wide manipulation potentiates new 
approaches for strain improvement by directed evolution on the organism level. 
These methods include global transcription machinery engineering (gTME), 
which is based on mutating transcription regulatory proteins and selecting for the 
desired phenotypes [354]. In another method, termed multiplex automated 
genome engineering (MAGE), cells are transformed with ssDNA 
oligonucleotides targeting specific sequences for replacement by recombination 
[355]. Using this method, the expression of 24 genes were simultaneously 
optimized by modulating the ribosome binding site sequences with degenerate 
oligonucleotides (and by knocking out alternate pathways), followed by a 
selection phase resulting in a fivefold increase in lycopene production in E. coli 
[355]. Moreover, there are aspirations to develop controllable regulatory 
elements in the host genome to modulate host metabolism on demand. For 
example, the specificity of estrogen receptor was changed to respond exclusively 
to two new synthetic ligands for the establishment of logical gates to shunt gene 
expression [356]. Another example of genetic circuits is the ligand-responsive 
riboswitches [337]. 
The rise of cell-free display platforms predicts accelerated selections on 
combinatorial repertoires in the future. The open operating system of the cell-free 
platforms, as well as the progress in engineering whole organisms to express 
orthogonal tRNA/aminoacyl-tRNA synthetase pairs, have enabled the 
incorporation of unnatural amino acids into proteins [357]. The unnatural amino 
acids widen the spectrum of physico-chemical properties of proteins beyond the 
natural counterparts establishing totally new application areas, e.g., in imaging 
and immunotherapy [358; 359]. Systems for the incorporation of unnatural amino 
acids have been further optimized by directed evolution [357]. Another 
dimension to be explored is the manipulation of binding polypeptides with 
chemical modifications to obtain novel functions. For example, the bicyclic 
peptides have been obtained by bridging three cysteines via a tris-
(bromoethyl)benzene moiety [360]. 
If we consider that the minimum tools for gene variant generation are PCR and 
oligonucleotide synthesis, the directed evolution of single genes has been 




practiced from the mid 1980s onward [113; 361]. Our understanding of the 
functional diversity creation is mostly based on the experiments conducted 
thereafter, and the rules of thumb for directed evolution continue to be clarified, 
experiment by experiment, allowing the future scientists to gain results of higher 
impact with less effort. The representative examples of the recent findings that 
the scaffolds with a polar active site-core structure correlate with evolvability 
[313] and that the tyrosine is a key residue for establishing molecular interactions 
at binding surfaces [122], will most likely turn into new guiding principles. 




3 AIMS OF THE STUDY 
Directed evolution is a central method for developing affinity reagents and 
enzymes for biotechnological industry, medicine and diagnostics. The aim of this 
study was to advance directed evolution research with novel methods for high 
quality gene library construction and for the improved display of proteins of 
interest on phage. As antibody phage display is an increasingly applied method, 
the intention was also to generate information on the differences between 
antibody diversification schemes and filamentous phage display platforms for 
maximum performance. 
More specifically the aims were: 
1. To improve an existing primer extension mutagenesis method with 
additional enzymatic reactions to produce larger libraries with a higher 
share of mutated members. 
2. To enhance the efficiency of error-prone RCA mutagenesis by tapping 
more transformants via genetic rearrangement. 
3. To develop tools for improved Fab display on M13 phage by directed 
evolution. 
4. To explore the properties of libraries derived from a single antibody 
scaffold via independent diversification schemes. 
5. To compare the performance of antibody fragment libraries displayed on 
filamentous phage as p3, truncated p3, and p9 fusions in biopanning 
experiments. 




4 SUMMARY OF MATERIALS AND METHODS 
A detailed description of the materials and methods can be found in the original 
publications (I-V). A summary of the used methods and most central materials 
are presented in Tables 2, 3, 4 and 5 below. Only the novel methods developed in 
this study are described in detail in section 4.2. 
4.1 Bacterial strains, vectors, reagents and methods 
Table 3. Bacterial strains. 
Bacterial strain Genotype Source Used in 
E. coli XL1-Blue 
hsdR17(rK- mK+) endA1 
gyrA96(nalR) thi-1 recA1 
relA1 supE44 lac  





E. coli SS320 
(MC1061 F´) 
hsdR mcrB araD139 
Δ(araABC-leu)7679 
lacX74 galU galK rpsL thi-1 
F'[ ::Tn10 proAB+lacIq 
Δ(lacZ)M15] 
[314] I-V 
E. coli K12 CJ236 
F∆(HindIII)::cat (Tra+ Pil+ 
CamR) ung-1 relA1 dut-1 









Table 4. Methods summary. 
Method Used in 
PCR, molecular cloning and sequencing I-V 
Kunkel mutagenesis I 
Selective RCA I 
Error-prone RCA II 
Concatemer reduction by Cre/LoxP recombination II 
Error-prone PCR III 
Phage stock preparation, phage titer determination and 
biopanning 
I,III,IV,V 
Protein expression and cell lysis III,IV,V 
MIC determination II 
Western blotting III 
TRFIA and ELISA screening III,IV,V 
Phage immunoassay III,IV,V 
Display efficiency determination III,V 
IC50 assays IV,V 
Biolayer interferometry IV,V 
Protein purification IV 
Methods written in bold were developed in this study. See detailed description 
below. 




Table 5. Vectors used for display and screening. 
Vector Description Resistance Source Used in 
pEB91 
Phage display as fusion to p9. 
Amber stop between POI and 
p9. 
cm [119] I,II 
pEB30 
Phage display as fusion to full-
length p3. 
cm III III,V 
pEB32x 
Phage display as fusion to 
truncated p3. 
cm IV IV,V 
pEB92 Phage display as fusion to p9. cm V V 
pEB07 
Soluble periplasmic expression 
as a fusion to β-lactamase. 
cm I I,IV,V 
pAK400 
Enhanced periplasmic 
expression. His tag purification. 
cm [362] III,V 
pAK400ampR 
Enhanced periplasmic 
expression. His tag purification. 
amp II II 
pLK06 
Soluble periplasmic expression 
as fusion to alkaline 
phosphatase. 
amp IV IV,V 
pLK06H 
Soluble periplasmic expression 
as fusion to alkaline 
phosphatase. His tag 
purification. 
amp IV IV 
pLK01 
Soluble periplasmic expression 
as fusion to mouse CL. Binds to 
RAM plate. His tag 
purification. 
amp IV IV 
cm: chloramphenicol and amp: ampicillin. 




Table 6. Reagents used in the study. 










































Goat anti-mouse IgG (H+L) biotin 
conjugated 
Zymed, USA III 
Antibody, 
monoclonal 




















Goat anti-rabbit IgG (Forton Bioscience, 


















Antigen Streptavidin BioSpa, Italy IV,V 








































































































4.2 Methods in detail 
4.2.1 Selective RCA 
Selective RCA (sRCA) is an enhanced version of the primer extension 
mutagenesis method described by T.A. Kunkel (schematic illustration of Kunkel 
mutagenesis in Figure 6) [155]. In Kunkel mutagenesis a uracil-containing 
single-stranded DNA is used as a template for the hybridization of a mutagenic 
primer. The extension of the primer and the ligation of the remaining nick yield a 
covalently closed circular dsDNA molecule. In sRCA, this product is treated with 
UDG and amplified by RCA instead of direct transformation. The removal of 
uracil bases by UDG from the template strand leads to the selective amplification 
of the nascently synthesized intact circular DNA strand carrying the desired 
mutations (Figure 10). 
This method and variants thereof are also described in article I. For a large-scale 
library construction, Kunkel-type primer extension mutagenesis was carried out 
with 5 µg template ss(U)DNA as described in [155; 314; 363]. The formed 
heteroduplex was treated with 10 U UDG at 37 °C for 1 h and purified with 
Qiagen PCR purification kit (Qiagen, Hamburg, Germany) to 50 µl 10 mM Tris-
HCl (pH 8.5). A 2 µl sample (240 ng i.e. 4×1010 molecules of vector pEB91-
ScFv) was amplified in 200 µl phi29 DNA polymerase reaction buffer containing 
1 mM dNTPs, 50 µM random primers, 4 mM DTT, 0.25 U inorganic 
pyrophosphatase, and 100 U phi29 DNA polymerase. The reactions were 
incubated overnight at 30°C and heat-inactivated at 70°C for 10 min. The DNA 
concatemer produced in RCA by phi29 DNA polymerase was digested with 200 
U HindIII to single-plasmid sized units in a 1 ml reaction volume overnight at 
37°C, and purified with miniprep kit columns (Qiagen, Hamburg, Germany) in 
the following way. The 1 ml digest was mixed with 5 ml binding buffer, applied 
in a 10 ml TERUMO-syringe (Terumo Corp., Tokyo, Japan), which was fastened 
tightly in a miniprep column. 3 ml of the digest per column was pressed through 
and, after loading, the purification was continued according to manufacturer's 
instructions with a final 100 µl elution volume in 10 mM Tris-HCl (pH 8.5). 
The HindIII-digested DNA was self-ligated overnight at 16°C by using 5 ng/µl 
DNA with 0.05 U/µl T4 DNA Ligase in the manufacturer's (Fermentas, St. Leon-
Rot, Germany) recommended buffer containing 40 mM Tris-HCl (pH 7.8), 10 
mM MgCl2, 10 mM DTT and 0.5 mM ATP. The concentration and purification of 
the ligation was carried out to 50 µl volume containing 230 ng/µl DNA with the 
syringe-method described above. Ligation was electroporated to freshly prepared 
SS320 cells by loading 230 ng DNA with 70 µl cells per 0.1 cm gap-with cuvette 
(Bio-Rad, USA) at settings 200 Ω, 1.25 kV, 25 µF (Gene Pulser, Bio-Rad, USA). 
Each cuvette was washed twice with 1 ml SOC, recovered at 37 °C with 100 rpm 
shaking for 1 h and plated on 24x24 cm Bioassay Dishes containing LA with 25 




µg/ml cm, 10 µg/ml tet and 1% glucose, 20 ml recovery per plate. Plates were 
left to dry 1 -2 h and grown o/n at 30 °C. 
4.2.2 Concatemer reduction by Cre/loxP recombination 
Error-prone RCA is carried out in a phi29 DNA polymerase catalyzed reaction in 
the presence of MnCl2 with a similar method as described by Fujii et al. [100]. 
For the concatemer resolution via recombination, a loxP site is inserted into the 
plasmid prior to amplification. In this study, loxP was ordered as two 
complementary oligonucleotides that, upon hybridization, readily created 
HindIII-compatible cohesive ends. The other HindIII recognition sequence in the 
loxP-cassette was ordered as non-palindromic with a designed point mutation to 
destroy the site in order to retain HindIII as a unique restriction site in the final 
loxP construct. 
This protocol can also be found in article II. Instead of using Templiphi kit in the 
error-prone RCA as used by Fujii et al., the reaction was self-formulated and 
contained the following components: the pAK400ampR vector with inserted loxP 
site was heat-denatured at 95 °C for 3 min. For error-prone RCA, 25 pg plasmid 
was amplified in 20 µl 1 x phi29 DNA polymerase buffer with 1.5 mM MnCl2, 
1 mM dNTPs, 50 μM random hexamers or exo-resistant random primers, 0.05 U 
inorganic pyrophosphatase, and 20 U phi29 DNA polymerase at 30 °C o/n. For 
recombination, the RCA reaction was heat-inactivated at 70 °C for 10 min and 
10 μl of the reaction was diluted in 50 μl Cre recombinase buffer supplemented 
with 1 U Cre recombinase and incubated at 37 °C for 2 h. Reaction was heat 
inactivated at 70 °C for 10 min and EtOH-precipitated with Pellet Paint Co-
precipitant (Merck, Darmstadt, Germany) to 10 μl volume. The original template 
DNA was removed by digesting 100 ng of the precipitated products with 2 
U DpnI in 10 μl volume at 37 °C for 2 h and transformed to E. coli SS320 cells. 
4.2.3 Display efficiency determination 
Display efficiency was determined as Fab (displayed molecule) signal per phage. 
The number of virion particles in the samples was determined by immunoassay. 
Phage quantitation by immunoassay requires a standard prepared in the same 
way as the samples, i.e. 2 x PEG/NaCl-precipitation, with a very well-known 
infectivity. The study Huovinen et al. 2010 involved multivalent Fab phage 
stocks and, therefore, a hyperphage stock of the Fab clone 4D5 was chosen as the 
relative phage particle number standard (rcfu, relative colony forming units) 
[article III]. The infective titer of the Fab4D5 stock was determined in three 
independent experiments by counting cmR-colonies. A dilution series of the Fab 
4D5 phage stock and sample phage stocks were applied on streptavidin plates 
coated with biotinylated mouse anti-M13 antibody. Bound phages were detected 
with a europium-labelled rabbit anti-fd (anti-phage) Ab. The titers of the 




unknown samples were determined from the linear-fit of the standard curve (only 
points at the linear response range included). 
Display efficiency determination is also described in article III, but a more 
detailed protocol is provided here. All washing steps in the phage titer 
immunoassay were done with 1296-026 Delfia Platewash using Innotrac Wash 
Buffer and all dilutions were done in Innotrac Assay Buffer containing 50 mM 
Tris–HCl, pH 7.75, 150 mM NaCl, 0.5 g/l NaN3, 0.1 g/l Tween 40, 0.5 g/l 
bovine-γ-globulin, 20 μM DTPA, 5 g/l bovine serum albumin (BSA), and 
20 mg/l cherry red. Biotinylated anti-M13 Ab was added on STR wells, 100 ng 
per well, and incubated at room temperature with slow shaking for 30 min. The 
plate was washed four times and sample phages (tenfold serial dilutions, 1:102 – 
1:105) and standard dilutions (105 cfu/ml - 108 cfu/ml) added 100 µl /well, 
incubated at room temperature with slow shaking for 1 h and washed four times. 
Europium-labelled anti-phage Ab was added, 13 ng per well, and incubated for 1 
h at room temperature with slow shaking. The label was washed four times, the 
wells enhanced with Delfia Enhancement solution for further 15 min, and the 
time-resolved fluorescence signal measured with Victor 1420 Multilabel Counter 
(Wallac Oy, Turku, Finland). 
For the determination of the Fab signal, another phage immunoassay was 
performed on rabbit anti-mouse IgG plates that capture the phage via displayed 
Fab-moiety. The same amount of phage particles (106 rcfu) were applied per well 
and the assay performed as described above. The display efficiency of the phage 
clones was calculated in relation to the RAM signal of the original FabD phage 
stock with the lowest Fab display level (value: 1). In article V, the display 
efficiency was calculated in relation to the highest RAM/phage-signal in the 
assay, i.e. hyperphage-superinfected pEB30-Fab phagemid. 




5 SUMMARY OF RESULTS AND DISCUSSION 
5.1 Selective RCA as a novel method to improve primer extension 
mutagenesis 
5.1.1 Kunkel vs. sRCA - summary of experiments 
The motivation for developing Kunkel mutagenesis further arose directly from 
the lab work as it was noticed that Kunkel mutagenesis resulted in an equal 
mixture of mutants and template, or sometimes even in a dominant share of the 
template background [article I]. This is an inherent property of Kunkel 
mutagenesis, which has been earlier solved either by using stop codons or 
restriction enzyme recognition elements at the site of mutagenesis [119; 314]. 
However, in the stop-codon-strategy the template is still present as a major 
contaminant in the library, albeit unable to be displayed, and in the latter template 
digestion-strategy, an additional purification step of the transformed library as 
dsDNA is required for efficient background removal followed by re-
transformation. In addition to losses in time and library quality, both of these 
strategies require prior manipulation of the template sequence and, therefore, 
they are not universally applicable to all sequences. 
As Kunkel product is circular DNA, it is an ideal substrate for rolling circle 
amplification. Initially, it was reasoned that nicking the template strand would 
destroy the amplification potential of the template, as only the nascently 
synthesized strand would be intact circular DNA. This was also proven to be an 
effective method with a USER enzyme mixture, containing both UDG for uracil 
excision and a DNA lyase for phosphate backbone nicking at the abasic sites. By 
further examination of the process, it was deciphered that only UDG is needed to 
confer the selectivity. This is most probably due to the fact that an abasic site in 
the template DNA is a strong stalling signal for the family B DNA polymerases 
[364], including phi29 DNA polymerase. Therefore, phi29 DNA polymerase-
driven RCA leads to selective amplification of only the nascently synthesized 
mutant strand (Figure 10). 





Figure 10.  Selective  rolling  circle  amplification  (sRCA)  flowchart.  The 
heteroduplex, ccc-ds(U)DNA formed in Kunkel mutagenesis (A), is treated with 
UDG (B) and subsequently amplified with RCA (C) using random hexamers as 
primers. The resulting DNA concatemer is cut to plasmid-sized units (D) and 
re-circularized by self-ligation (E) for host transformation. From article I. 
These findings were confirmed in three separate studies [article I]. The first 
proof-of-principle experiment was carried out with a CDR-H1 oligonucleotide 
coding for 30 genetic variants. An AatII restriction site was present in the 
template ScFv gene at the site of CDR-H1 for genetic analysis of the outcome. 
Only 3/10 clones originating from transformed Kunkel product were mutated by 
analyzing single DNA clone preparations by AatII digestion, whereas after 
selective RCA, all the picked ten clones were mutants (Table 7). In the next 
experiment, the achievable library size and compatibility to incorporate PCR 
products was explored. Fourteen VH genes were incorporated into a uridylated 
VL-library present as ssDNA and consisting of 1 x 108 members. Transformation 
of 240 ng UDG-treated Kunkel product directly and after RCA, resulted in a 
library of 3 x 107  and 1 x 1010 cfu, respectively. In this experiment the 
mutagenesis efficiency was determined for the Kunkel reaction treated with 
UDG, which was surprisingly high (85%) compared to earlier findings. 
Naturally, the UDG treatment itself increases the mutagenesis efficiency, but only 
by 10% in our experiments [article I]. Selective amplification raised the 
efficiency to 100%. 
In the final experiment a ScFv-β-lactamase fusion gene was used as the template 
containing three stop codons at the CDR-H3 site [article I]. The mutagenesis 
outcome was easily followed in this system by plating transformed cells on 
selective agar plates. The mutagenic primer contained seven consecutive NNN 
codons with a calculated complexity of 109 variants. The implementation of 
sRCA produced similar improvement in the amount of DNA and the number of 
transformants in both the CDR-H3 mutagenesis experiment as in the preceding 
VH gene incorporation experiment. The mutagenesis efficiency was increased 
from 45% obtained with Kunkel mutagenesis to 100% with sRCA. In this 
experiment, unmodified random hexamers were used, whereas with thio-resistant 
hexamers only 90% mutagenesis efficiency was obtained. Surprisingly, 
mutagenesis efficiency was decreased to 0.1% by RCA without UDG treatment 
indicating the strict dependency of selectivity on the removal of uracils from the 
template strand. 














30 1 x 109 14 
Combinatorial 
diversityb 
30 1 x 109 1x 1010 
Kunkel, DNA N.D. 10 ng 240 ngc 
after sRCA, 
DNA 
N.D. 525 ng 12 µg 
Kunkel, cfu N.D. 4x 105 3 x 107c 
after sRCA, 
cfu 
N.D. 8 x 107 1 x 1010 
Kunkel Mut-% 30% 45% 85%c 
after sRCA 
Mut-% 
100% 90 – 100%d 100% 
aTheoretical number of unique variants in the incoming variable DNA element. 
bThe pre-existing diversity in the template taken into account. 
cAfter UDG treatment. 
d90% efficiency with exoresistant and 100% with unmodified random primers. 
5.1.2 Elimination of template-mutant coexistence by sRCA 
Mutagenesis efficiency in the CDR-H3 experiment was re-analysed using colony 
PCR [article I]. In addition to stop codons, a SacII site was present in the 
template at the CDR-H3 site. Therefore, the amplicon is resistant to cleavage by 
SacII, if mutagenesis has been successful. In a sample group of 20 colonies 
originating from the Kunkel sample 8/20 amplicons were perfectly cleaved by 
SacII, 8/20 were cleavage-resistant and the remaining 4/20 were only partially 
digested (Table 8). A control amplicon derived from the wild-type template was 




totally digested by SacII in the same conditions indicating that both mutated and 
unmutated phagemids had propagated in the 4/20 clones. No partial digestion 
was observed among the tested sRCA clones in the SacII test. Naturally, in sRCA 
with exoresistant primers 2/20 amplicons were fully sensitive to SacII as they 
were template clones. 
To verify the presence of double templates in the Kunkel sample, we decided to 
test a new set of colonies from the selective ampicillin-containing plate, which 
only allows growth of the mutants with the open reading frame. A pair of primers 
was used: the forward primer hybridized only to the wild-type template sequence 
at the CDR-H3 site and the reverse primer hybridized outside the mutated region. 
In this way, smaller amounts of template DNA could be detected than by 
digesting the amplicon. In the case of Kunkel heteroduplex, 11/34 clones yielded 
PCR product indicating that the unmutated template DNA was still present in 
32% of the clones considered to be mutants [article I]. Template specific PCR of 
ampR colonies originating from the sRCA transformation yielded no PCR 
products. 
Table 8. Colony PCR screen of clones created with primer extension 
mutagenesis of CDR-H3 loop. 
Treatment K K+U K+U+R K+U+R 
Random hexamers none none exoresistant normal 









8/20 9/20 18/20 20/20 
SacII-
sensitive 




4/20 3/20 0/20 0/20 













11/34 16/34 0/31 0/34 
 K: Kunkel, U: UDG, R: RCA, cm: chloramphenicol, and amp: ampicillin. 




5.1.3 Extensions of sRCA and future prospects 
The template in Kunkel heteroduplex may be rendered unfavourable for rolling 
circle amplification also by other strategies than uracil incorporation. Nicking 
endonucleases cut one DNA strand in their recognition element depending on the 
orientation of the sequence element [365]. This phenomenon was utilized by 
treating a primer extended covalently closed dsDNA heteroduplex with a nicking 
endonuclease that cuts only the template strand, after which the intact strand 
carrying the mutations was favourably amplified in the following RCA reaction 
(data not shown). However, the development of this method was not continued 
further as uracil-based sRCA is at least equally potent. Moreover, the nicking 
endonuclease-dependent method requires the presence of a nicking site that cuts 
only the template strand, whereas the uracil strategy is universal. Although sRCA 
has been demonstrated to build E. coli hosted libraries, the ability to produce 
unlimited amount of mutated DNA may find even more use in library 
construction in other host organisms such as yeasts, e.g. Kluyveromyces lactis, in 
which the heterologous gene is directly targeted for chromosomal integration 
requiring a large amount of linear DNA in transformation [366]. 
5.2 Enhancement of error-prone RCA mutagenesis by concatemer 
reduction to circular monomeric units 
Error-prone RCA is an easy-access tool for whole-plasmid mutagenesis. It is 
claimed to be the most simple mutagenesis method as there is no need for a 
thermal cycler or specific primers [367]. RCA is turned error-prone by MnCl2 and 
by reducing template DNA concentration. In the earlier reports on error-prone 
RCA, the DNA concatemer formed in the multiply-primed RCA reaction is 
directly transformed to host and segregation to single plasmid units is speculated 
to occur by homologous recombination in the host cells [100]. In a test reaction 
to modulate the catalytic specificity of β-lactamase to hydrolyze also ceftazidime, 
none or only few ceftazidime resistant (ctzR) colonies were obtained due to very 
low transformation efficiency [article II]. Therefore, methods were sought to 
improve the transformability of the DNA concatemer in E. coli, which can be 
achieved, for example, by modifying the DNA into plasmid-sized circular units. 
The recircularization may be accomplished by digestion with a unique restriction 
enzyme and subsequent ligation in conditions favouring self-ligation [368]. This 
method, however, requires two enzymatic reactions and a DNA purification step. 
In this study, this procedure was replaced with Cre/loxP recombination 
containing a single recombinase addition and incubation step to yield highly 
transformable circular DNA [article II]. When loxP site is present in the target 
plasmid the DNA concatemer produced in a RCA reaction is an ideal substrate 
for the Cre recombinase catalyzing the excision of the intervening DNA between 
two adjacent loxP sites in a circular form (Figure 11) [369]. 




This concept was tested on an ampicillin-resistant plasmid carrying the TEM-1 β-
lactamase gene by first inserting a loxP element in the plasmid and then performing 
RCA in error-prone and nonerror-prone conditions. It was found that digestion-
ligation and recombination performed with equal efficiency and were superior to 
direct concatemer transformation in terms of the number of obtained transformants. 
Recombination produced 20 - 50-fold and 13-fold more transformants per reaction 
than the direct transformation of the concatemer, in nonerror-prone and error-prone 
conditions, respectively [article II]. The less significant increase in the number of 
transformants observed in the error-prone condition is most probably explained by 
the inhibitory effect of MnCl2 on the amplification. Due to the reduced 
amplification, the concatemer unit at the end of the reaction is smaller and, therefore, 
more easily transformed than in nonerror-prone conditions. 
Based on seven experiments, the average numbers of ampR colonies with and 
without recombination were 13 036 ± 6700 cfu and 1183 ± 596 cfu per error-
prone RCA reaction, and the numbers of ceftazidime resistant colonies were 115 
± 57 and 9 ± 11 cfu, respectively [article II]. The practical benefit of concatemer 
resolution is that a full 96-well plate of ctzR colonies can be picked from a single 
transformed reaction as was also demonstrated in this study. To obtain the same 
number of colonies by the transformation of the intact concatemer, the collection 
of all transformants from ten reactions is required. Naturally, inserting loxP into 
the template plasmid requires some effort, but especially in repeatedly used 
vector systems, loxP option is a time-saving solution. A major limitation of 
epRCA is the high fidelity of phi29 DNA polymerase [370] limiting the acquired 
mutagenesis efficiency. A modified version of phi29 DNA polymerase retaining 
strand displacement activity and processivity, but having an inherently decreased 
fidelity, would be a more ideal enzyme for epRCA. 
 
 
Figure 11. Error-prone RCA with concatemer resolution by Cre/loxP 
recombination. A LoxP cassette is hybridized from two complementary DNA 
strands creating directly cohesive ends. The cassette is inserted into a circular 
plasmid. After error-prone RCA the resulting concatemer is resolved into 
monomeric circular units with Cre recombinase.  




5.3 Directed evolution as a powerful tool to improve oligovalent 
Fab display on M13 phage 
5.3.1 Improved chimeric Fab display on phage by the use of iterative 
cycles of phage production and selection with rabbit anti-mouse IgG 
antibodies 
Small antigens have only few epitopes available for antibody binding. Consequently, 
multivalent phage display systems would be beneficial to rescue also those clones 
that have at least a weak interaction with the antigen. Bearing this in mind, a 
chimeric Fab template was constructed consisting of codon-optimized human 
variable domains and mouse constant domains and displayed on filamentous phage 
with hyperphage superinfection. Hyperphage is a filamentous phage without p3 
gene and, therefore, all p3 in hyperphage-packed particles originates from the 
expressed phagemid [217]. In combination with full-length p3-Fab expression from 
a phagemid, every p3 should carry the displayed fusion moiety. 
The initial multivalent display efficiency of the chimeric Fab on the phage was 
poor. In order to improve the display, the Fab cassette was randomly mutated by 
epPCR, displayed on phage and selected on microtiter plates coated with rabbit 
anti-mouse IgG antibodies (RAM). Selections were carried out both in multi- and 
monovalent formats using lower (B) and higher (A) mutagenesis frequency. 
Enrichment for better display was observed in all stocks, but it was superior in 
libraries with higher mutation frequency (Figure 12) [article III]. 
 
Figure 12. Phage immunoassay of the enrichment of Fab-displaying phages. 1 x 
107 phages of each panning round were applied to Maxisorp wells coated with 
rabbit anti-mouse IgG. Bound phages were detected with a europium-labelled 
anti-phage antibody. Circles: oligovalent libraries; triangles: monovalent 
libraries; black: more mutated library A; and green: less mutated library B. 
Adapted from article III. 


















5.3.2 Two mutations found to affect phage propagation and display 
efficiency 
Clones were picked from the third round of panning for primary and secondary 
screening and nine confirmed positive clones were chosen for closer genetic 
analysis. Major deletions in the Fab molecule, or a frameshift, was found in all 
chosen 5/5 library A members and thus, only the less mutated library B clones 
turned out to be a valuable source of candidates for further studies [article III]. 
Two different genotypes were observed among the four sequenced library B 
members, one of which contained an amber stop codon in VH, which abolishes 
Fab expression in a non-supressor host. Logically, further investigations were 
concentrated on the remaining clone with seven mutations that were segregated 
from each other to study their individual effects in more detail. 
Two out of seven mutations were found to have a profound effect on the phage 
biology [article III]. One of them, Y102LF (FabF), was located in the core of 
variable light domain close in sequence to the CDR-L3 loop, while the other 
mutation caused a change in the start codon of the PelB signal sequence of the 
heavy chain to code valine instead of methionine (FabMGUG). Hyperphage-
produced FabF and FabMGUG variants had titers ten- and twofold higher, and Fab 
display efficiencies 12- and 19-fold higher than the wild type FabD, respectively 
(Table 9). The phage titer of the double mutant was additively increased but the 
display efficiency was only slightly, if at all, enhanced. 




Table 9. Genetic determinants and phage titers of a selected set of clones 













































a Error bars represent the SD of three independent experiments. 
5.3.3 Forces of selection and forced display 
There are clearly two selection pressures in the described panning experiment 
aimed at improving the oligovalent display of Fab molecules. One is the selection 
for the ability to bind to the provided coating (RAM) on the microtiter plate and 
the other is the selection for better propagation in the phage amplification phase. 
As shown with the cell culture assay, the Fab expression in general has toxic 
effects on the cells, which are further enhanced by isopropyl-β-D-
thiogalactopyranoside (IPTG) induction (Figure 13) [article III]. Especially, the 
growth of the original FabD-p3 fusion was the most severely retarded. Against 
this background, it is easy to conceive that in order to gain a healthier living the 
Fab gene must be dropped or the expression burden alleviated. This was also 
observed in most of the studied variants as deletions, frameshifts, or amber stop 
codons. 
 





Figure 13. Growth curves of selected clones. (A) Growth curves of clones 
expressing soluble Fab with 100 µM IPTG (open symbols) and without (filled 
symbols). (B) Growth curves of clones expressing Fab–p3 fusion with 100 µM 
IPTG (open symbols) and without (filled symbols). FabD: squares (green); FabF: 
circles (blue); FabMGUG: triangles up (red); XL1-Blue strain without plasmid: 
triangles down (black). Data are expressed as the mean ± SD of three 
independently grown cultures. Adapted from article III. 
The most striking example of a fit clone was the most wide-spread library A 
variant lacking the heavy chain altogether and containing a direct light chain 
fusion to the p3 [article III]. This construction is half the size of a Fab, can easily 
produce viable phage particles in the forced display system, and is able to bind 
on the RAM plate. According to the results of this study, caution must be taken in 
applying the hyperphage system. In the forced display concept, an equal valency 
display of all variants is anticipated, but this is clearly variating and it seems that 
even some bald phages are also present. This is most probably explained by 




































differences in the proteolytic degradation propensity of the fusion moieties, 
which has also been observed by others [371]. Furthermore, survival of out-of-
frame constructs was encountered in this and also in another study on applying 
hyperphage to enrich open reading frames from a cDNA fragment library [372]. 
5.4 Augmentation of the overall functional performance of an 
antibody library by complementary diversity created by 
independent randomization schemes 
5.4.1 Key differences in library design of ScFvP and ScFvM repertoires 
The principle design features of the ScFvP library (anti-protein repertoire) were 
to set the majority of the diversity in the heavy chain, especially at the apex of 
CDR-H1, CDR-H2, and CDR-H3 loops. Moreover, there was length variation 
from 7 to 18 residues in CDR-H3 closely following the natural human CDR-H3 
repertoire with a mean at 13 residues [373]. In ScFvM (anti-multipurpose) 
repertoire, the light chain was more diversified than in the ScFvP repertoire by 
adding variation into the CDR-L1 and CDR-L3 loops. The heavy chain diversity 
in the ScFvM design, regarding the CDR-H1 and CDR-H2 loops, was shifted 
“down the β-strand”, when viewed from the top of the paratope towards the 
centre of the antigen binding site, to support contacts with peptide and hapten 
targets (Figure 14). 
 
Figure 14. Cartoon presentation of the randomized positions on VH (left) and 
VL (right) looking at the antigen binding site from above. The positions having 
variation only in the ScFvP and ScFvM repertoire are marked with yellow and 
blue, respectively. The shared randomized positions are coloured green and the 
positions randomized in the CDR-H3 loop are marked in red. Adapted from 
article IV. 
The loop length variation in the CDR-H3 of ScFvM repertoire was limited to 
short loops of 5 to 12 residues. Although the mean CDR-H3 length of the 




observed anti-hapten antibodies in natural repertoires, at ten residues, is on the 
upper limit of the input lengths [374], it is necessarily not the optimal length 
distribution for hapten recognition, but an innate constraint from germ-line 
repertoire and the editing process. Therefore, a shorter CDR-H3 repertoire than 
that provided by nature was explored as the source of antigen-binding motifs. 
Moreover, we observed that 86.3% of those antibodies with very short loop 
lengths, 4 - 7 aa, comprising only 1.7% of all human antibodies are lacking the 
salt bridge Arg(Lys)106H-Asp116H (R106H-D116H) at the CDR-H3 stem region 
(Figure 15). This observation was taken into account in the ScFvM repertoire by 
severely restricting the occurrence of the R106H-D116H salt bridge. 
 
 
Figure 15. Salt bridge R(K)106H-D116H frequency in human CDR-H3 (N = 
4751) length groups (IMGT definition). The analysis is based on the 
supplementary data set provided by Zemlin et al. [373]. The overall salt bridge 
frequency differed very significantly from the length-independent distribution 
(χ2 value 318, 6 degrees of freedom, p < 0.0000001, loop lengths ≤ 3 excluded as 
they cannot form a salt bridge). Neighbouring length groups with significantly 
different salt bridge frequencies are highlighted (χ2 test of independence, *** = 
p < 0.0000001). From article IV. 
5.4.2 ScFvM is a superior source of peptide and hapten antibodies 
ScFvM and ScFvP repertoires were panned in parallel and as a mixture against 
different antigens. In parallel selections against streptavidin, the same number of 
unique antibodies was obtained from both repertoires with the highest measured 
apparent affinity found from the ScFvP repertoire (Table 10) [article IV]. In 
parallel anti-digoxigenin (anti-DIG) selections, the ScFvM library provided 




higher affinity variants than the ScFvP repertoire. The predominant share of 
retrieved antibodies from the mixed panning experiments that recognized PSA 
originated from the ScFvP library, whereas all the retrieved anti-McLR and anti-
DIG antibodies originated from the ScFvM repertoire based on the origin 
identification by sequencing. A closer scrutiny of the sequence details of the 
ScFvM members revealed that the highest affinity anti-DIG and anti-McLR 
antibodies contained short CDR-H3 loops of four and five residues, respectively, 
and were without the canonical salt bridge, whereas the CDR-H3 of the highest 
affinity anti-PSA antibody contained eleven residues with a constraining salt 
bridge [article IV]. A summary of selections is presented in Table 10. 














M STR 60 000 88/96 8/8 6/8 M: 6 
Kda:  
6.3 ± 1.6 nM 
(M-STR1)b 
P STR 60 000 72/90 8/8 6/8 P: 6 
Kda:  
2.2 ± 1.0 nM 
(P-STR3)b 
M DIG 391 47/87 8/8 6/8 M: 6 
IC50:  
158 ± 20 nM 
(M-DIG1)b 
P DIG 391 59/87 8/8 4/7 P: 4 
IC50:  
1544 ± 42 nM 
(P-DIG3) 




5.3 ± 1.0 nM 
(M-PSA1) 




22.8 ± 2.1 nM 
(M-MCLR1) 




361 ± 74 nM 
(M-DIG8)b 




Antigens: STR: streptavidin; DIG: digoxigenin; PSA: prostate specific antigen; 
and MCLR: microcystin-LR. Screen I: primary screening (pos./all) and Screen 
II: secondary screening (pos./ selected). All affinity data is based on at least 
three independent measurements. aApparent affinity of a dimer binding to 
streptavidin. bMeasured with purified proteins. 
5.4.3 Selection outcome with ScFvM and ScFvP repertoires indicate 
complementary functional diversity 
The final selection of clones against PSA from the mixed library sample was 
performed with two PSA-capturing antibodies that recognized different epitopes 
on the opposite sides of a PSA molecule. Five unique clones were found from the 
5A10-PSA-panning [article IV]. Among these, the antibodies able to bind to the 
target in the presence of both 5E4 and 5A10 were exclusively from the ScFvP-
repertoire (Figure 16). In contrast, the only clones from the 5E4-PSA-panning 
with any binding ability towards PSA complexed with 5A10 were from the 
ScFvM-repertoire. Consequently, selected anti-PSA antibodies from ScFvM- and 
ScFvP-library were able to recognize different epitopes on PSA. Another 
indication of complementary diversity was observed in the IC50 assays of anti-
DIG clones as two ScFvP anti-DIG clones were able to bind the biotinylated 
digoxigenin, but did not respond to the free digoxigenin [article IV]. Similar 
clones were not captured from the ScFvM repertoire. 
 





Figure 16. Binding profiles of the extracted anti-PSA antibodies. The ability of 
the ScFvM (black bars) and ScFvP (white bars) clones to bind PSA as captured 
on solid-phase either with antibody 5A10 (bars up) or 5E4 (bars down). The 
origin of the clones, i.e. the selection sample from which they were derived, is 
indicated below the graph. The error bars represent the SD of the intra-assay 
variation with three replicas. Adapted from article IV. 
In this study, it was demonstrated that by diversifying different residues even the 
same framework can be modified to provide two libraries with distinct binding 
profiles. In some studies reported earlier, the likelihood of finding affinity 
reagents for peptides and haptens was increased by constructing libraries on an 
antibody scaffold known to bind a member of the target class [326; 327]. In the 
present strategy, the fundamental principles governing the molecular recognition 
of different sized antigens was explored in a more disclosed fashion as the 
starting scaffold was a germ-line gene pair and not an antigen-specific scaffold. 
Therefore, the principles of molecular recognition of different-sized antigens can 
be deciphered from the randomization scheme. Unfortunately, the single 
representative antigens of different classes does not form a panel versatile 
enough to make conclusions, for example, on the correlations between CDR-H3 
loop length and the presence of salt bridge in relation to target size. Experiments 
with more antigens of various size and chemical nature are required to further 
clarify the underlying principles with relevant statistical rigor. 




5.5 Selection performance of an antibody library and the chosen 
phage display format 
5.5.1 Genetic fusion to capsid proteins p3, p3∆ and p9 support Fab display 
but with different efficiencies 
Despite the popularity of phage display, no library-scale studies have been 
conducted to compare the selection performance of a library fused to different 
capsid proteins for display. In this study, an identical antibody repertoire was 
displayed as Fab-p9, -p3, -p3∆ and ScFv-p3∆ fusions on the filamentous phage 
(Figure 17) and, thereafter, the selection performance was followed in repeated 
parallel panning reactions against streptavidin and digoxigenin. The effect of 
valency modulation on the enrichment and diversity of binding phages was 
studied by superinfecting the Fab-p3 library with hyperphage in parallel with the 
conventional VCS-M13 superinfection. 
We were able to display the Fab library as a fusion to all tested capsid proteins. 
There was, however, a decrease in the display efficiency of the Fab molecules 
monitored as Fab/phage-ratio with a sequence: hyperphage-packed Fab-p3 > 
VCS-M13-packed Fab-p3∆ > VCS-M13-packed Fab-p3 > VCS-M13-packed 
Fab-p9 (Figure 18). The display efficiency of ScFv could not be determined in 
the same assay as it does not bind to RAM-plates, but in an earlier study carried 
out with protein L, the ScFv display efficiency was higher as p3∆ than as p9 
fusion [119], which is in accordance with the current study. The poor display of 
Fab-p9 (3.2% of the Fab/phage-ratio obtained for hyperphage-packed Fab-p3) 
was reflected as markedly slower enrichment or even as a failed experiment in 
the applied selection conditions [article V]. More than three rounds are, therefore, 
recommended with Fab-p9 or similar constructs to obtain a satisfying frequency 
of binding clones. Nevertheless, display via p9 can be considered as a true 
monovalent display technique, which may be a beneficial feature in the most 
stringent affinity selections. However, the high number of bald phages must be 
taken into account, when deciding the number of input phage particles.  





Figure 17. Phage display formats and genetic constructions. Antibody 
fragments were displayed as N-terminal fusions to the C-terminal phage capsid 
protein. The capsid genes used for display were the full-length gene-3 (g3), the 
truncated gene-3 (g3Δ) lacking the infection domains and the gene-9 (g9). Lac 
operon (Lac P/O) was used to express the constructs and PelB leader peptides 
were used for periplasmic translocation via the SEC-pathway. 
 
Figure 18. The influence of the phagemid and helper phage on the display level 
as normalized A) by total phage mass and B) by infectivity. Black: hyperphage 
Fab-p3; white: VCS-M13 Fab-p3; light grey: VCS-M13 Fab-p3∆; and dark grey: 
VCS-M13 Fab-p9. The error bars represent the SD of three independent 
experiments in figure A and the SD of the intra-assay variation of three replicas 
in figure B. 




5.5.2 Display efficiency and proliferation bias influence the clonal diversity 
of the retrieved clones 
Significant loss of functional diversity was observed both after hyperphage and 
VCS-M13 packing in the Fab-p3 repertoire (Table 11). An increase in the 
number of frameshift mutants was also evident in ScFv-p3∆ repertoire, but to a 
lesser extent. Accordingly, a lower number of unique specific Fab clones were 
obtained from Fab-p3 than from Fab-p3∆ libraries, especially as regards 
digoxigenin selections (Table 12). The diversity of the Fab-p3 repertoire was 
better retained by oligovalent than monovalent display. However in this study, 
the use of hyperphage did not result in the emergence of a clone that would have 
superior characteristics compared to the clones obtained by other display formats. 
The advantage of oligovalent display is even more questionable, as the highest 
number of unique specific clones was obtained from p3∆ display libraries. In 
particular, the highest diversity and affinity antibodies against digoxigenin were 
retrieved from ScFv-p3∆ repertoire with IC50 values of 112 ± 24 nM and 158 ± 
20 nM (Figure 19). 
A fast enrichment is not always a guarantee for quality. Especially in the 
monovalent Fab-p3 library, a single anti-DIG monoclone overtook the output. 
The same clone was observed to be the highest affinity anti-digoxigenin antibody 
in all screened Fab-p3 outputs and also found in the first set of Fab-p3∆ and Fab-
p9 selections. There are alternative explanations for this phenomenon: a low 
initial diversity, a true challenge (no better clones available), the strong 
secondary fitness characteristics of the clone, or cross-contamination of the 
panning reactions. For the most part, the last alternative was excluded by a 
restriction analysis of the phagemid DNA after selection. Naturally, the phagemid 
leakage between Fab-p3 libraries (VCS-M13- and hyperphage-infected) is 
indiscernible and a minor contamination in other libraries is not necessarily 
visible on stained agarose gels. Consequently, contamination cannot be 
completely ruled out. 
As DIG is a small hapten, the carrier protein streptavidin is exposed to the phages 
and available target in selection reactions. Therefore, a DTT elution strategy was 
devised, which in principle should selectively rescue only the digoxigenin-bound 
phages by cleaving the linker between DIG and STR. Despite the DTT elution, 
an enrichment of anti-STR clones was observed in DIG selections. This was most 
probably due to the presence of clones with various affinities against STR and 
the law of mass action. During the elution (30 min) also STR-binders were 
dissociated from the carrier and included to continuation. This could be avoided 
by alternating the carrier between STR and avidin, after which no enrichment of 
anti-STR phage was observed [articles IV and V].  
Although ScFv seems to be superior to Fab in display, the conversion of ScFv 
into Fab or directly to full-length IgG may bring unpleasant surprises. Some 
groups have observed a decrease in affinity upon conversion [375], although 
attention must be paid to possible change in valency as ScFv may form dimers or 




higher multimer structures [376], whereas Fab is generally considered to be a 
monomeric molecule. Possibly due to these issues or easier format-conversion of 
Fab to full-length IgG, many recent large antibody repertoires have been 
constructed in Fab format [157; 158]. It is of crucial importance to consider the 
display related aspects as the chosen format may bias the outcome. Furthermore, 
as pointed out by the carrier dilemma, selection conditions should be considered 
with prudence to avoid wrong conclusions on the library potential based on a 
weak experimental execution. 















LC-BLA 2x 107 None 8/8 - - 
pEB07-Fab Fd-BLA 3x 108 None 8/8 - - 
pEB30-Fab Fd-p3 3x 109 None 22/24 - - 




1.8 ± 0.3 
x1012 
2.9 ± 1.0  
x1011 
pEB30-Fab Fd-p3 -“- VCS-M13 8/22 
7.1 ± 0.5 
x1013 




Fd-p3Δ 1x 109 VCS-M13 22/24 
1.5 ± 0.6 
x1014 
1.1 ± 0.1  
x1014 
pEB92-Fab Fd-p9 5x 109 VCS-M13 22/23 
3.3 ± 0.2 
x1014 




Fd-p3Δ 6x 109 VCS-M13 21/34 
3.2 ± 0.3 
x1014 
3.1 ± 7.4  
x1014 
 













N D Highest aff. (IC50) N D Highest aff. (IC50) 
Fab-p3 Hyperphage 8 1 442 ± 37 nM 8 4 442 ± 37 nM 
Fab-p3 VCS-M13 8 1 442 ± 37 nM 8 2 442 ± 37 nM 
Fab-p3 Hyper>VCS 8 1 442 ± 37 nM 8 1 442 ± 37 nM 
Fab-p3∆ VCS-M13 7 4 442 ± 37 nM 7 5 1.5 ± 0.1 µM 
ScFv-
p3∆ 
VCS-M13 8 4 158 ± 20 nM 8 6 112 ± 24 nM 
Fab-p9 VCS-M13 3 2 442 ± 37 nM 0 0 N.D. 
 
Figure 19. IC50 assay of the three highest affinity anti-DIG antibodies from Fab 
and ScFv repertoires. The clone marked with a filled square found in Fab-p3, 
Fab-p3∆ and Fab-p9. The clone marked with a filled diamond found in Fab-p3∆. 






The nature of directed evolution practiced by humankind has expanded from the 
traditional breeding concept to a detailed molecular level fine-tuning of single 
genes and metabolic pathways by designed gene libraries and elaborate selection 
techniques. Despite the continuously accumulating knowledge of biomolecules, 
rational design is still totally dependent on directed evolution to finalize design 
solutions [357]. Therefore, novel library concepts that focus on the most relevant 
diversity, potentiating tools that encompass larger clonal repertoires, and an 
understanding of the factors affecting selections are vital information in bringing 
modern biotechnology forward. 
In this thesis, new solutions and insights have been provided in multiple focus 
areas of laboratory-driven directed evolution. The first two research articles (I 
and II) described new techniques to improve gene variant library construction. In 
the first study, a method, termed selective RCA, was introduced. This tool 
increases the number of transformants and reduces the template background in 
the final library. In the second study, the efficiency of the simplest random 
mutagenesis method, termed error-prone RCA, was further enhanced with 
Cre/loxP-recombination. Especially sRCA has obtained attention in the 
biotechnology community as a welcome update to Kunkel mutagenesis published 
in 1985 [155]. Surprisingly, the sRCA study was cited for the first time on 
account of the finding that phi29 DNA polymerase is capable of using uridylated 
DNA as template [377]. This is a demonstration among others that applied 
science may also contribute to basic science. 
In the third study (III), a universal method for improving the display of 
immunoglobulins on phage was described and the role of the found mutations on 
the display properties discussed. Antibody fragments are foreign molecules to E. 
coli that may severely disturb the host metabolism as demonstrated with the 
growth experiments of Fab expressing cells in article III. Against this 
background, it is quite evident that knowledge on the functional aspects of the 
chosen platform will ultimately lead to a more cost-effective product 
development. Unfortunately, there are only few research articles on comparing 
the properties of the well-established display platforms to support researchers. 
This lack of information was the incentive for the article V. In this study, the 
selection performance of an identical antibody repertoire as a fusion to different 
filamentous phage capsid proteins was followed. It was observed that Fab display 
level on phage was lower as a fusion to p9 than to p3, which in turn, lead to the 
less efficient enrichment of the binding clones in the p9 repertoire. As a 
conclusion, in order to maximize the diversity of the output clones in primary 
library selections, truncated p3 display is a vital alternative, whereas p9 display 
may be an option for affinity maturation schemes, in which lower valency of 
displayed molecules is an advantage. 
In the fourth research article (IV) a synthetic biology approach was undertaken to 





demonstrated that the reactivity profile of a library could be shifted by targeting 
different positions in the framework and that both libraries (ScFvP and ScFvM) 
had their own strengths as the source of antibodies depending on the nature of the 
target. As exemplified by this study, limiting the searched structural sequence 
space by the rational design of library diversity, the probability of obtaining more 
specific antibodies against the desired group of antigens is increased. Conversely, 
knowledge obtained from the rationally designed focused libraries may also 
provide new insights into the mechanisms of molecular recognition in general, 
which is the basis of more efficient synthetic repertoires in the future. 
The results presented here contribute to the sciences of experimental directed 
evolution and synthetic biology that are under continuous development by 
academic groups and private companies. The grand visions in directed evolution 
are to harness novel enzymes to produce sustainable energy for all and to deliver 
drugs to cure diseases that were once considered incurable. While we are not yet 
there, these kind of initiatives are already on the way [378], progressing with an 
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